Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3052592	f-noroag	— (—)	800	1048	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Non-invasive ventilation

251

32.39

307.65

1.4

1.2

—

Intestinal infectious diseases

349

433

6.02

175.48

1.4

1.2

—

Bacterial pneumoniae

216

210

9.10

165.90

1.5

1.2

—

Bacterial pneumonia, not elsewhere classified

210

199

9.34

164.39

1.5

1.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

262

373

6.30

148.91

1.4

1.2

—

Bacterial pneumonia (organism specified)

224

297

6.88

138.86

1.5

1.3

—

Other bacterial intestinal infections

132

108

12.39

133.51

1.6

1.3

—

Other bacterial diseases

298

394

5.03

119.16

1.5

1.2

—

Other bacterial intestinal infections, including avohilmo

137

144

9.61

116.81

1.6

1.3

—

Septicaemia

195

274

6.53

115.68

1.5

1.2

—

Intestinal infectious diseases, including avohilmo, including avohilmo

333

405

4.59

112.00

1.4

1.2

—

Explicit Sepsis

197

295

6.12

109.77

1.5

1.2

—

Other septicaemia

178

254

6.65

108.97

1.6

1.2

—

Explicit Sepsis, including avohilmo

197

297

6.05

108.32

1.5

1.2

—

Bacterial intestinal infections, IBD co-morbidities

131

144

9.22

108.08

1.6

1.3

—

Bacterial infection, other or unspecified

206

295

5.92

107.81

1.6

1.2

—

Infections, IBD-co-morbidities

25.50

107.07

1.7

1.4

—

Other septicaemia, including avohilmo

178

260

6.47

105.93

1.6

1.2

—

Bacterial infection, other or unspecified, including avohilmo

214

312

5.65

105.54

1.6

1.2

—

Bacterial Sepsis

204

292

5.81

103.85

1.6

1.2

—

Enterocolitis due to Clostridium difficile

102

12.37

102.85

1.7

1.3

—

All pneumoniae

273

397

4.48

95.44

1.5

1.2

—

Implicit bacterial Sepsis

183

272

5.80

94.48

1.7

1.2

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

277

406

4.39

94.04

1.4

1.2

—

Other bacterial diseases, including avohilmo

278

396

4.39

93.52

1.5

1.2

—

Pneumonias (Asthma/COPD co-morbidities)

268

399

4.40

91.93

1.5

1.2

—

Implicit bacterial Sepsis, including avohilmo

188

285

5.52

91.11

1.6

1.2

—

Influenza and pneumonia

269

377

4.41

90.55

1.5

1.2

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

263

404

4.35

89.64

1.5

1.2

—

Care involving use of rehabilitation procedures

211

405

4.70

88.19

1.5

1.2

—

Pneumonia, organism unspecified

229

361

4.36

79.36

1.5

1.2

—

Implicit Sepsis

219

373

4.34

77.48

1.6

1.2

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

228

295

4.53

77.38

1.5

1.2

—

228

295

4.53

77.38

1.5

1.2

—

Any death

178

273

4.58

65.89

1.5

1.2

—

Certain infectious and parasitic diseases

189

194

4.89

64.97

1.4

1.2

—

Complications of medical and surgical care

213

524

3.66

64.26

1.5

1.3

—

Implicit viral Sepsis

101

151

6.74

64.23

1.6

1.3

—

Viral Sepsis

101

151

6.74

64.23

1.6

1.3

—

Viral and other specified intestinal infections

8.92

63.97

1.3

—

Acute tubulo-interstitial nephritis

186

398

3.96

61.37

1.5

1.2

—

All kidney diseases

240

464

3.47

61.15

1.4

1.2

—

Renal tubulo-interstitial diseases

230

483

3.50

60.99

1.5

1.2

—

Fever of other and unknown origin

161

323

4.33

60.29

1.6

1.2

—

Oxycodone

136

234

4.99

59.98

1.5

1.3

—

Implicit Sepsis, including avohilmo

206

397

3.72

59.09

1.5

1.2

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

238

512

3.14

52.16

1.4

1.3

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

173

474

3.59

52.01

1.5

1.3

—

Heart failure, not strict

180

332

3.65

49.49

1.3

—

Viral and other specified intestinal infections, including avohilmo

125

6.34

48.62

1.3

1.4

—

Implicit viral Sepsis, including avohilmo

106

218

4.88

48.08

1.5

1.3

—

Condition for Implicit Sepsis (Organ dysfunction codes)

195

404

3.35

47.79

1.5

1.2

—

Asthma, unspecified (mode), excluding more controls

109

153

5.11

46.20

1.3

1.1

—

Asthma, unspecified (mode)

115

174

4.78

45.50

1.2

1.1

—

Complications of surgical and medical care, not elsewhere classified

234

539

2.90

44.91

1.4

1.3

—

Persons encountering health services for specific procedures and health care

229

451

3.00

44.79

1.4

1.2

—

Noninfective enteritis and colitis

131

338

3.88

44.46

1.6

1.2

—

All influenza

142

5.59

41.84

1.4

1.3

—

Erysipelas

134

314

3.69

40.58

1.4

1.2

—

Anaemias

11.05

40.32

1.5

1.3

—

Erysipelas, including avohilmo

155

348

3.31

38.16

1.4

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

184

417

2.98

37.29

1.5

1.2

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

152

487

3.12

36.95

1.5

1.3

—

Viral pneumonia

7.55

36.03

1.6

1.3

—

Heart failure,strict

131

254

3.61

36.03

1.4

1.3

—

Transplanted organ and tissue status

9.23

35.64

1.4

—

Dialysis, with operation codes

7.03

35.13

1.8

1.3

—

Caries of dentine

155

4.88

35.08

1.5

1.4

—

COPD (mode)

101

5.58

34.69

1.2

1.1

—

Bleeding

191

483

2.78

34.57

1.5

1.3

—

Asthma, excluding more controls

124

161

3.96

34.33

1.3

1.1

—

Oral corticosteroids

219

488

2.63

34.09

1.4

1.3

—

First line medication for Crohn's disease

215

429

2.70

34.09

1.5

1.2

—

Inflammatory bowel disease treatment related agents

230

496

2.58

33.70

1.4

1.2

—

Asthma

131

182

3.72

33.56

1.3

1.1

—

Ulcerative colitis, NAS

7.43

33.46

2.0

1.4

—

All chronic kidney diseases

133

324

3.28

33.13

1.6

1.3

—

Asthma (mode)

128

182

3.70

32.85

1.2

1.1

—

Acute renal failure

201

4.25

32.70

1.7

1.3

—

Nephropathy related operations

6.64

32.69

1.8

1.4

—

Noninfectious colitis NAS

6.63

32.68

1.9

1.3

—

COPD/asthma/ILD related infections

176

295

2.99

32.53

1.4

1.2

—

COPD/asthma related infections

176

295

2.99

32.53

1.4

1.2

—

Ulcerative colitis

142

4.95

32.49

1.7

1.3

—

Complications of procedures, not elsewhere classified

177

521

2.74

32.48

1.5

1.3

—

Any gastric operation

127

171

3.73

32.34

1.5

1.1

—

GASTRO-related operations

127

171

3.73

32.34

1.5

1.1

—

Aplastic and other anaemias

133

395

3.09

31.20

1.3

—

Other noninfective gastroenteritis and colitis

175

4.42

31.13

1.8

1.3

—

Liquid cancers, including Hilmo

102

247

3.65

30.77

1.6

1.3

—

All-cause Heart Failure

145

333

3.04

30.65

1.4

1.3

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7.40

30.51

1.3

1.5

—

Asthma-related pneumonia

111

332

3.34

30.28

1.3

—

Asthma-related pneumonia or sepsis

111

332

3.34

30.28

1.3

—

Asthma, hospital admissions 3, pneumonia

111

332

3.34

30.28

1.3

—

Heart failure, strict

145

338

2.99

29.86

1.4

1.3

—

Renal failure

138

397

2.97

29.72

1.7

1.3

—

Dental caries

177

4.23

29.70

1.5

1.3

—

Other functional intestinal disorders

115

322

3.25

29.35

1.3

—

Diseases of the digestive system

127

419

3.02

29.20

1.5

1.3

—

IBD patients in KELA-register

114

5.20

28.98

1.8

1.3

—

ILD medications: prednisolone, methylprednisolone, prednisone

209

466

2.50

28.90

1.4

1.3

—

Other pulmonary diagnosis

124

182

3.42

28.11

1.4

1.1

—

Other anaemias

124

387

3.01

27.98

1.3

—

Other and unspecified anaemias

123

385

3.01

27.78

1.3

—

ILD medications

212

470

2.43

27.61

1.4

1.3

—

Inflammatory bowel disease

212

3.83

27.20

1.7

1.3

—

L04AD Calcineurin inhibitors

7.65

27.17

1.5

—

Excluding asthma or asthma-COPD overlap

122

182

3.36

27.05

1.4

1.1

—

ILD medications: immunosuppressive drugs

128

403

2.88

26.62

1.5

1.3

—

Other medical care

113

306

3.11

26.25

1.5

1.3

—

COPD differential diagnosis

120

182

3.31

26.00

1.4

1.1

—

ILD differential diagnosis

120

182

3.31

26.00

1.4

1.1

—

Nausea and vomiting

195

3.86

25.97

1.2

1.3

—

Inflammatory bowel disease, strict (require KELA)

127

4.66

25.60

1.8

1.3

—

Asthma, hospital admission 2, infections

138

502

2.69

25.58

1.3

—

Asthma-related infections

138

502

2.69

25.58

1.3

—

Asthma (only as main-diagnosis), excluding more controls

103

161

3.54

25.55

1.3

1.1

—

Agranulocytosis

6.71

25.47

1.7

1.3

—

Mucosal proctocolitis

7.29

25.41

1.5

1.4

—

Asthma (only as main-diagnosis)

109

182

3.35

25.12

1.3

1.1

—

Malaise and fatigue

110

281

3.09

24.90

1.3

1.2

—

Budesonide

5.64

24.70

1.6

1.3

—

Heart failure and coronary heart disease

110

248

3.12

24.41

1.5

1.3

—

Early onset COPD, excluding more controls

5.73

24.04

1.2

1.1

—

Other diseases of intestines

189

441

2.39

24.03

1.4

1.3

—

Other diseases of the digestive system

305

3.16

24.00

1.5

1.4

—

GI-bleeding

306

3.15

23.86

1.5

1.4

—

Implicit fungal Sepsis, including avohilmo

8.64

23.65

2.0

1.2

—

5-aminosalicylic acid

117

4.63

23.27

2.0

1.3

—

Unspecified acute lower respiratory infection

5.03

23.21

1.8

1.4

—

General symptoms and signs

175

355

2.47

23.11

1.5

1.2

—

Liquid cancers

224

3.43

22.85

1.7

1.3

—

Nutritional anaemias

122

432

2.70

22.78

1.4

1.3

—

Other CVD (FINNGEN)

7.89

22.69

1.5

1.3

—

Asthma (diagnoses ohter than nonallergic)

173

604

2.32

22.62

1.3

—

Autoimmune diseases excluding thyroid diseases, strict definition

190

446

2.32

22.53

1.4

1.3

—

Autoimmune diseases related-to ILD

167

599

2.33

22.32

1.4

1.3

—

Autoimmune diseases excluding thyroid diseases

194

464

2.27

21.88

1.4

1.3

—

Other diseases of blood and blood-forming organs, wide

158

3.94

21.70

1.6

1.2

—

Certain infectious and parasitic diseases, including avohilmo

102

158

3.24

21.52

1.5

1.2

—

Organic, including symptomatic, mental disorders

123

323

2.68

21.15

1.4

1.3

—

Primary_lymphoid and hematopoietic malignant neoplasms

208

3.48

21.02

1.6

1.3

—

Paralytic ileus and intestinal obstruction

205

3.47

20.71

1.5

1.3

—

ILD medications: azathioprine

5.43

20.67

1.9

1.2

—

Ulcerative colitis (strict definition, require KELA)

5.08

20.66

1.9

1.4

—

Sequelae of external causes of morbidity and mortality

201

3.50

20.63

1.5

1.3

—

Streptococcal septicaemia

6.71

20.39

1.3

1.1

—

Other degenerative diseases of the nervous system

119

3.93

20.29

1.2

1.3

—

Sequelae of cerebrovascular disease

292

2.88

20.13

1.3

—

Oedema, not elsewhere classified

215

3.32

19.82

1.3

1.2

—

Azathioprine

5.22

19.81

1.8

1.3

—

Constipation

170

515

2.24

19.81

1.3

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

4.96

19.66

1.9

1.4

—

Opioids

158

343

2.38

19.60

1.5

1.3

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

4.66

19.56

1.8

1.3

—

Alzheimer disease, excluding more controls

4.63

19.19

1.3

—

Other special examinations and investigations of persons without complaint or reported diagnosis

123

233

2.68

19.11

1.4

1.3

—

Cerebrovascular diseases (FINNGEN)

4.45

18.99

1.3

1.2

—

Other disorders of urethra and urinary system

137

396

2.41

18.98

1.2

—

Intestinal stricture

277

2.97

18.56

1.6

1.3

—

Streptococcal septicaemia, including avohilmo

6.08

18.56

1.3

1.1

—

Care involving dialysis

6.88

18.24

1.5

1.3

—

Chronic lower respiratory diseases

207

535

2.04

17.97

1.3

—

Explicit bacterial Sepsis

5.51

17.87

1.4

1.2

—

Stroke, excluding SAH

124

368

2.44

17.77

1.4

1.3

—

STROKE

231

2.80

17.74

1.3

1.2

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

172

541

2.13

17.69

1.3

—

Symptoms and signs involving the urinary system

149

505

2.23

17.67

1.3

—

Any dementia, excluding more controls

237

2.76

17.17

1.3

—

Symptoms and signs involving the digestive system and abdomen

166

380

2.19

17.03

1.5

1.3

—

Diseases of oesophagus, stomach and duodenum

185

531

2.06

17.01

1.3

—

Explicit bacterial Sepsis, including avohilmo

5.26

16.99

1.4

1.2

—

Extracorporeal dialysis

7.56

16.97

1.5

1.4

—

Any dementia

103

273

2.62

16.88

1.3

—

Crohn disease

5.66

16.77

1.8

1.4

—

Misadventures to patients during surgical and medical care

102

4.24

16.64

1.2

1.3

—

Heart failure and bmi 25plus

219

2.78

16.54

1.4

1.3

—

Osteopathies and chondropathies

115

443

2.38

16.52

1.4

1.3

—

Other disorders of skin and subcutaneous tissue

144

561

2.17

16.43

1.4

1.3

—

Dyspnoea

165

573

2.08

16.38

1.3

—

Iron deficiency anaemia

100

393

2.50

16.28

1.4

1.3

—

Hypertensive diseases (excluding secondary)

129

3.25

16.27

1.3

1.4

—

Headache

103

317

2.51

16.08

1.2

—

Other viral diseases

178

3.31

16.08

1.6

1.3

—

Other neurological diseases

142

507

2.17

16.03

1.4

1.3

—

Stroke, including SAH

123

380

2.33

15.98

1.3

—

Other disorders of fluid, electrolyte and acid-base balance

256

2.84

15.94

1.4

1.3

—

Insulin medication

121

436

2.31

15.93

1.4

1.3

—

188

471

2.02

15.93

1.4

1.3

—

Other chronic obstructive pulmonary disease

292

2.61

15.90

1.2

1.4

—

COPD

299

2.59

15.89

1.2

1.4

—

Cerebrovascular diseases

141

447

2.19

15.80

1.3

—

Other or unspecified ileus, impaction or obstruction

138

3.64

15.71

1.6

1.3

—

Pain in throat and chest

143

385

2.20

15.59

1.3

—

Ischaemic Stroke, excluding all haemorrhages

116

364

2.35

15.52

1.3

—

COPD related to multimorbidity

297

2.60

15.49

1.2

1.3

—

Other acute lower respiratory infections

111

455

2.33

15.37

1.6

1.3

—

Intracranial trauma

216

2.72

15.36

1.4

1.2

—

346

2.56

15.24

1.3

1.4

—

Hard cardiovascular diseases

136

362

2.22

15.17

1.4

1.3

—

Transient ischemic attack

108

362

2.38

15.16

1.3

—

Sequelae with surgical and medical care as external cause

156

3.41

15.15

1.3

—

Concussion

216

2.80

15.08

1.2

—

Metabolic disorders

160

464

2.07

15.06

1.4

1.3

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

5.46

14.95

1.2

1.3

—

Later onset COPD, excluding more controls

4.05

14.82

1.3

1.1

—

Nerve, nerve root and plexus disorders

186

575

1.94

14.78

1.3

—

Missing teeth due to accident, extraction or parodontitis

122

494

2.21

14.78

1.4

1.3

—

Bronchitis

188

585

1.93

14.61

1.4

1.3

—

Abdominal and pelvic pain

158

380

2.09

14.54

1.3

—

Diseases of the respiratory system

149

2.83

14.46

1.4

1.1

—

Vascular dementia (undefined)

6.57

14.30

1.3

1.2

—

Low back pain

137

436

2.12

14.19

1.3

—

Chronic kidney disease

319

2.54

14.13

1.7

1.3

—

Cardiac arrhythmias

202

2.67

14.11

1.3

—

Other viral diseases, including avohilmo

245

2.79

14.09

1.5

1.4

—

Other diseases of pleura

100

369

2.36

14.07

1.6

1.3

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

243

2.81

14.02

1.3

—

Codeine

136

340

2.16

13.95

1.3

—

Diseases of arteries, arterioles and capillaries

132

458

2.12

13.83

1.3

—

Cytomegalovirus infection, IBD co-morbidity

20.42

13.82

2.1

1.1

—

Other symptoms and signs involving cognitive functions and awareness

370

2.35

13.76

1.3

—

Hypertensive diseases

112

272

2.32

13.72

1.4

1.3

—

Type of accident

224

2.86

13.72

1.3

—

Hypertension

112

272

2.32

13.72

1.4

1.3

—

Hernia of abdominal wall, postoperative

4.81

13.61

1.3

1.1

—

Abnormalities of breathing

142

389

2.09

13.59

1.3

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

128

532

2.10

13.57

1.3

—

Insulin, combination of fast acting with intermediate-acting or long-acting

121

515

2.13

13.54

1.4

1.3

—

COPD, hospital admissions

332

2.39

13.53

1.2

1.3

—

Enlarged lymph nodes

4.03

13.50

1.5

1.3

—

Any reimbursement code in KELA

103

3.17

13.44

1.4

1.0

—

Cytomegaloviral disease

18.55

13.41

2.0

1.1

—

Cytomegaloviral disease, including avohilmo

18.54

13.40

2.0

1.1

—

COPD-related respiratory insufficiency

3.94

13.40

1.1

1.4

—

Epilepsy

243

2.75

13.36

1.7

1.3

—

Substance abuse, excluding more controls

321

2.40

13.34

1.5

1.3

—

Other heart diseases, wide

136

393

2.10

13.31

1.3

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

162

524

1.95

13.29

1.4

1.2

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

4.46

13.28

1.8

1.4

—

COPD, early/later onset

335

2.36

13.16

1.2

1.3

—

Haemorrhage from respiratory passages

255

2.61

13.12

1.3

—

Asthma/COPD (KELA code 203)

156

533

1.96

13.03

1.3

—

Major coronary heart disease event excluding revascularizations

110

324

2.24

12.99

1.4

1.3

—

Unstable angina pectoris

238

2.58

12.98

1.5

1.3

—

Percutaneous Coronary Intervention

127

364

2.12

12.89

1.4

1.2

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

4.26

12.85

1.3

1.2

—

Gastrointestinal diseases

131

2.83

12.84

1.4

1.2

—

Myocardial infarction

264

2.41

12.83

1.5

1.3

—

L04AA Selective immunosuppressants

143

3.30

12.81

1.4

—

Tramadol

118

325

2.18

12.80

1.5

1.3

—

Pure hypercholesterolaemia

131

400

2.08

12.77

1.3

—

Candidiasis, including avohilmo

217

2.82

12.72

1.5

1.2

—

Implicit fungal Sepsis

12.37

12.61

2.0

1.3

—

Other respiratory disorders and diseases

191

2.94

12.61

1.8

1.3

—

Other diseases of the respiratory system

191

2.94

12.61

1.8

1.3

—

Fungal Sepsis

12.36

12.61

2.0

1.3

—

Alzheimer disease

261

2.42

12.52

1.4

1.3

—

Vocal cord dysfunction

5.07

12.47

1.4

1.2

—

Other heart diseases

134

2.96

12.44

1.3

1.4

—

Parasetamol

201

2.42

12.41

1.4

—

Dizziness and giddiness

129

494

2.03

12.38

1.2

1.3

—

Insulin, intermediate and long-acting

107

481

2.15

12.38

1.4

1.3

—

Second line medication for Crohn's disease

100

455

2.20

12.33

1.5

1.3

—

Hypertension, essential

107

269

2.25

12.26

1.4

1.3

—

Osteoporosis

229

2.66

12.08

1.5

1.3

—

Fentanyl

4.04

12.05

1.3

1.4

—

Cardiovascular diseases (excluding rheumatic etc)

166

2.62

12.01

1.4

1.3

—

Degenerative diseases of the nervous system

286

2.32

12.00

1.3

—

Vascular disorders of the intestines

5.25

12.00

1.6

1.4

—

Heart failure and antihypertensive medication

3.53

12.00

1.4

1.2

—

Disorders of thyroid, IBD co-morbidities

5.57

12.00

1.3

—

Covid-19 confirmed case

354

2.35

11.94

1.2

1.3

—

Candidiasis

3.82

11.88

1.6

1.4

—

Coronary revascularization (ANGIO or CABG)

124

364

2.07

11.85

1.4

1.2

—

Multiple myeloma and malignant plasma cell neoplasms

5.89

11.80

1.5

1.4

—

Ischemic heart diseases

129

378

2.03

11.70

1.4

1.3

—

Vascular dementia

3.88

11.65

1.4

—

Glomerulonephritis

4.75

11.64

1.5

—

Other and unspecified nerve root and plexus disorders, also in other diseases

142

3.18

11.59

1.2

1.3

—

Schizophrenia or delusion, excluding more controls

171

2.95

11.56

1.5

1.3

—

Any mental disorder

161

425

1.90

11.54

1.3

—

Mycoses

218

2.71

11.50

1.5

1.3

—

Procreative management

162

2.85

11.45

1.3

1.5

—

Dementia

290

2.24

11.39

1.3

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

229

2.55

11.35

1.2

1.4

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

203

2.77

11.33

1.3

1.4

—

Type 2 diabetes, wide definition

133

425

1.97

11.32

1.4

1.3

—

Unspecified haematuria

301

2.30

11.27

1.2

1.3

—

ILD, hospital admission 2, with pulmonary infections

5.13

11.25

2.0

1.3

—

Other ulcerative colitis

9.64

11.23

2.1

1.6

—

Other/unspecified cytomegaloviral diseases

17.36

11.23

1.8

1.1

—

Dysphagia

188

2.83

11.16

1.4

—

Myocardial infarction, without ST-elevation

363

2.22

11.03

1.4

1.3

—

Malignant neoplasm of digestive organs

246

2.40

11.02

1.4

1.3

—

Myocardial infarction, strict

252

2.33

11.00

1.5

1.3

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

142

3.11

10.95

1.3

—

Angina pectoris

290

2.20

10.92

1.4

1.3

—

COPD, hospital admission 2, with asthma infections

261

2.41

10.88

1.2

1.3

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

103

385

2.10

10.87

1.5

1.3

—

Non-follicular lymphoma

4.11

10.86

1.7

1.4

—

Short Achilles tendon (acquired)

15.65

10.84

1.1

1.7

—

Ischaemic heart disease, wide definition

120

366

2.02

10.82

1.4

1.2

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

118

3.32

10.78

1.6

1.4

—

ILD, hospital admissions 3, with pneumonia sepsis

4.92

10.72

2.0

1.4

—

Symptoms and signs involving the nervous and musculoskeletal systems

104

509

2.05

10.72

1.3

—

Lower back pain or/and sciatica

173

605

1.78

10.70

1.3

—

Major coronary heart disease event

131

402

1.95

10.67

1.4

1.2

—

Pneumonia due to other infectious organisms, not elsewhere classified

13.01

10.66

1.7

1.2

—

Malignant neoplasm

130

389

1.96

10.65

1.5

1.2

—

Autoimmune diseases

167

466

1.82

10.61

1.5

1.3

—

Malignant neoplasm

130

390

1.95

10.58

1.4

1.3

—

Unspecified mental disorder

281

2.42

10.57

1.4

—

Fall on same level

168

496

1.81

10.56

1.3

—

Unspecified fall

463

2.08

10.54

1.3

—

Acute sinusitis

338

2.23

10.54

1.4

1.3

—

Pulmonary heart disease, diseases of pulmonary circulation

300

2.37

10.52

1.3

—

Kela-code for severe mental illness

252

2.50

10.51

1.4

—

Unspecific neurodegenerative disorder

301

2.17

10.50

1.2

1.3

—

Postprocedural musculoskeletal disorders, not elsewhere classified

4.82

10.48

1.2

1.4

—

Early onset COPD

146

3.02

10.46

1.2

1.4

—

Codeine or tramadol medication

175

536

1.77

10.43

1.3

—

Dementia, including avohilmo

314

2.13

10.43

1.3

—

Retention of urine

249

2.37

10.39

1.3

—

Amputation

3.70

10.39

1.6

1.4

—

Emergency coronary revascularization (for ACS)

138

440

1.89

10.37

1.4

1.2

—

Alzheimer’s disease (Late onset), excluding more controls

3.72

10.37

1.4

1.3

—

Other chronic obstructive pulmonary disease, including avohilmo

100

396

2.08

10.36

1.2

1.3

—

Malignant neoplasm, including Hilmo

131

395

1.93

10.34

1.6

1.3

—

Decubitus ulcer and pressure area

4.29

10.30

2.1

1.4

—

Non-Hodgkin lymphoma, all, including Hilmo

102

3.45

10.26

1.7

1.4

—

Crohn's disease NAS

8.81

10.26

1.9

1.5

—

L04AX Other immunosuppressants

444

2.10

10.25

1.6

1.3

—

Cardiovascular diseases

134

2.62

10.21

1.3

1.4

—

Coronary atherosclerosis

104

316

2.08

10.19

1.4

1.2

—

Diverticular disease of intestine

111

342

2.02

10.11

1.4

1.2

—

Abnormal findings on examination of blood, without diagnosis

378

2.13

10.09

1.3

—

Delirium, not induced by alcohol and other psychoactive substances

103

3.40

10.07

1.6

1.4

—

Syncope and collapse

262

2.33

10.04

1.4

1.2

—

Obesity related asthma

240

2.50

10.03

1.3

—

Gout

213

2.50

10.02

1.5

1.3

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

4.46

10.00

1.3

1.4

—

Glomerular diseases

129

3.11

9.99

1.5

1.3

—

Other diseases of anus and rectum

228

2.54

9.96

1.2

1.3

—

Non-allergic asthma (mode), excluding more controls

3.91

9.86

1.4

1.1

—

Viral pneumonia (known virus, not influenza)

10.74

9.80

1.8

1.3

—

Diseases of liver

273

2.39

9.80

1.4

1.3

—

Recurrent aphthous stomatitis , including avohilmo

3.53

9.74

1.2

1.4

—

Alzheimer’s disease (Atypical or mixed)

114

3.22

9.73

1.5

1.3

—

Valvular heart disease excluding rheumatic fever

243

2.27

9.62

1.3

—

Alzheimer disease, including avohilmo

284

2.15

9.62

1.2

1.3

—

Drug-induced neutropenia

5.03

9.56

1.8

1.4

—

Pulmonary heart disease

270

2.38

9.56

1.3

—

Pulmonary embolism

270

2.38

9.56

1.3

—

Colectomy operation

138

2.98

9.54

1.6

1.3

—

Multiple myeloma, including Hilmo

7.17

9.50

1.5

1.4

—

Polyarthropathies

110

359

1.97

9.42

1.4

1.3

—

Diseases of peritoneum

3.87

9.39

1.3

1.4

—

Malignant neoplasm, wide definition

128

397

1.88

9.34

1.5

1.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

154

553

1.76

9.33

1.3

—

Use of hypnotics and sedatives

164

539

1.74

9.33

1.3

—

Non-rheumatic valve diseases

242

2.24

9.30

1.3

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

4.51

9.30

1.3

1.5

—

Adrenocortical insufficiency

8.73

9.29

1.2

1.6

—

Malignant neoplasm of digestive organs, including Hilmo

255

2.22

9.29

1.4

1.3

—

Presence of cardiac and vascular implants and grafts

313

2.09

9.27

1.4

1.3

—

Neurological diseases

109

273

2.01

9.23

1.4

1.2

—

Functional dyspepsia

191

2.62

9.21

1.3

—

Anxiety disorders, excluding more controls

114

378

1.93

9.19

1.2

1.3

—

Non-allergic asthma (mode)

3.71

9.16

1.4

1.1

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

110

3.19

9.15

1.2

1.4

—

Disorders of gallbladder, biliary tract and pancreas

156

557

1.74

9.12

1.3

—

Other specified/unspecified bacterial intestinal infections

5.03

9.09

1.3

1.4

—

Disorders of other endocrine glands

379

2.11

9.08

1.3

—

Total colectomy

8.34

9.07

2.1

1.3

—

Total colectomy operation

8.34

9.07

2.1

1.3

—

Drug-induced adrenocortical insufficiency

15.83

9.06

1.3

1.1

—

Other diseases of urinary system

147

463

1.78

9.06

1.3

—

Problems related to lifestyle

3.98

9.04

1.4

—

Multiple myeloma

10.13

9.04

1.4

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

10.13

9.04

1.4

—

Diabetes, insulin treatment (Kela reimbursement)

156

533

1.74

9.02

1.5

1.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

122

2.69

8.98

1.4

1.2

—

Used for control exclusion in common control thyroid runs

153

436

1.77

8.97

1.5

1.3

—

Any event in cancer register

132

421

1.83

8.96

1.5

1.2

—

Other symptoms and signs involving the nervous and musculoskeletal systems

336

2.18

8.91

1.3

—

Other and unspecified iron deficiency

329

2.19

8.91

1.3

—

Gout, FINNGEN

265

2.33

8.88

1.5

1.3

—

Atrial fibrillation and flutter with reimbursement

3.53

8.80

1.6

1.2

—

General examination and investigation of persons without complaint and reported diagnosis

232

2.08

8.79

1.4

1.3

—

Gastro-oesophageal reflux disease

108

481

1.90

8.79

1.2

1.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

143

2.84

8.75

1.7

1.3

—

Stomatitis and related lesions

129

2.95

8.74

1.2

1.3

—

Other disorders of adrenal gland

7.21

8.73

1.2

1.5

—

Viral infections characterized by skin and mucous membrane lesions

339

2.15

8.71

1.3

—

Convulsions, not elsewhere classified

133

2.90

8.67

1.2

—

Venous thromboembolism

482

1.94

8.66

1.3

—

Substance abuse

432

1.98

8.66

1.5

1.3

—

Failure and rejection of transplanted organs and tissues

16.61

8.59

1.5

1.3

—

Adalimumab

4.77

8.58

1.7

1.4

—

Asthma, including avohilmo

179

594

1.66

8.57

1.2

1.3

—

Focal epilepsy

164

2.69

8.53

1.9

1.3

—

Exclusions for E4_PCOS_BROAD

105

3.15

8.46

1.3

1.4

—

Other viral diseases, not elsewhere classified

105

3.14

8.42

1.4

1.3

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

152

2.73

8.40

1.2

1.3

—

Diffuse large B-cell lymphoma, helper endpoint

6.72

8.36

1.8

1.4

—

Diffuse large B-cell lymphoma, including Hilmo

6.72

8.36

1.8

1.4

—

Diffuse large B-cell lymphoma

6.72

8.36

1.8

1.4

—

Non-ischemic cardiomyopathy

179

2.44

8.36

1.3

—

Asthma, hospital admissions , main diagnosis only

129

639

1.76

8.30

1.3

—

Schizophrenia or delusion

208

2.46

8.26

1.5

1.4

—

Genitourinary diseases

144

2.34

8.21

1.7

1.3

—

Other and unspecified nonorganic psychotic disorders

102

3.14

8.20

1.5

1.4

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

3.21

8.19

1.5

—

DVT of lower extremities and pulmonary embolism

393

2.03

8.19

1.3

—

Peripheral artery disease

355

1.98

8.19

1.3

—

Secondary and unspecified malignant neoplasm of lymph nodes

3.92

8.14

1.9

1.4

—

Zoster [herpes zoster]

157

2.68

8.12

1.3

—

Schizophrenia, schizotypal and delusional disorders

210

2.43

8.10

1.5

1.4

—

Suicide or other Intentional self-harm

135

2.82

8.08

1.8

1.4

—

Mental and behavioural disorders due to psychoactive substance use

437

1.93

8.06

1.5

1.3

—

Dialysis

8.97

8.04

1.6

1.3

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

141

484

1.73

7.99

1.5

1.3

—

Infections of the skin and subcutaneous tissue

473

1.92

7.98

1.3

—

Benzodiazepine use

154

622

1.67

7.95

1.4

1.3

—

Sequelae of injuries, of poisoning and of other consequences of external causes

165

2.61

7.91

1.7

1.4

—

Viral hepatitis, IBD co-morbidity

13.05

7.87

2.6

1.7

—

Kidney transplant status

7.78

7.87

1.4

1.5

—

Other problems related to primary support group, including family circumstances

4.10

7.84

1.2

1.3

—

Intracranial injury

489

1.87

7.83

1.5

1.3

—

Lung diseases due to external agents

121

2.90

7.83

1.4

1.3

—

Protozoal diseases

10.89

7.80

1.7

1.2

—

Protozoal diseases, including avohilmo

10.88

7.80

1.7

1.2

—

Diagnoses used for exclusion with ILD

220

2.37

7.80

1.5

1.3

—

Allergic asthma (mode), excluding more controls

3.38

7.74

1.3

1.1

—

Secondary hypertension

5.99

7.73

1.3

—

Neuromuscular dysfunction of bladder

3.73

7.62

1.2

1.4

—

Pneumocystosis, including avohilmo

12.01

7.60

1.8

1.3

—

Pneumocystosis

12.01

7.60

1.8

1.3

—

Crohn's disease of large intestine

8.05

7.59

2.3

1.5

—

Sequelae of other external causes

6.17

7.53

1.4

1.5

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

7.43

7.53

2.2

1.4

—

Convalescence

7.13

7.47

2.1

1.1

—

Tubulo-interstitial nephritis, not specified as acute or chronic

4.24

7.47

1.5

—

Other soft tissue disorders, not elsewhere classified

139

464

1.70

7.46

1.2

1.4

—

Other arrhythmias

346

1.92

7.45

1.1

1.3

—

Allergic asthma (mode)

3.30

7.45

1.3

1.1

—

Undetermined asthma, excluding more controls

4.39

7.40

1.3

1.1

—

Diseases of the skin and subcutaneous tissue

141

415

1.71

7.37

1.4

1.3

—

Volume depletion

3.35

7.37

1.6

1.3

—

Dermatitis

101

547

1.81

7.34

1.3

—

Mood disorders, excluding more controls

124

417

1.75

7.33

1.2

1.3

—

Atrial fibrillation and flutter

2.97

7.32

1.5

1.2

—

Other diseases of oesophagus

3.61

7.29

1.4

—

Provisional assignment of new diseases of uncertain etiology

472

1.87

7.25

1.2

1.3

—

Fall involving bed

6.27

7.25

1.2

1.4

—

Other CVD

209

2.35

7.25

1.4

—

Other intervertebral disc disorders

125

430

1.73

7.22

1.2

1.3

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

138

2.69

7.22

1.8

1.3

—

Other reaction to severe stress, and adjustment disorders

228

2.28

7.20

1.1

1.4

—

Insulin, fast-acting

293

2.12

7.16

1.4

—

Iron deficiency anaemia secondary to blood loss (chronic)

133

2.71

7.16

1.5

1.3

—

Papulosquamous disorders

307

2.09

7.13

1.2

1.3

—

All influenza (not pneumonia)

3.55

7.13

1.3

1.4

—

Codes for special purposes

475

1.86

7.12

1.2

1.3

—

Amputation of toe

3.77

7.07

1.6

1.5

—

Disorders of mineral metabolism

4.06

7.07

2.1

1.2

—

Use of other anti-dementia drugs

271

2.05

7.06

1.3

—

Use of memantine

271

2.05

7.06

1.3

—

Pain in limb

123

454

1.72

7.05

1.2

1.4

—

Alcohol use disorder, Swedish definition

403

1.90

7.04

1.3

—

Symptoms and signs involving the circulatory and respiratory systems

133

390

1.71

7.03

1.4

1.3

—

Other dorsopathies, not elsewhere classified

144

449

1.67

7.01

1.3

—

Cardiac arrest

6.14

6.95

1.4

—

Glomerular disorders in diseases classified elsewhere

3.30

6.95

1.6

1.5

—

Osteonecrosis

5.84

6.91

1.3

1.6

—

Hypotension

183

2.41

6.90

1.5

1.4

—

Episodal and paroxysmal disorders

152

471

1.64

6.89

1.4

1.3

—

431

1.84

6.88

1.3

—

Abnormal findings on diagnostic imaging of lung

418

1.88

6.87

1.3

—

Other antidepressants

148

459

1.65

6.87

1.2

1.4

—

Postprocedural disorders of digestive system, not elsewhere classified

8.31

6.83

1.7

1.4

—

Other and unspecified drugs and medicaments

3.79

6.80

1.3

1.4

—

Intestinal adhesions without obstruction

3.79

6.80

2.0

1.3

—

Other specified and unspecified personality disorders

4.26

6.74

1.9

1.5

—

Other condition

3.08

6.72

1.3

1.4

—

Purpura and other haemorrhagic conditions

3.08

6.72

1.7

1.4

—

Status post-ami

165

2.30

6.70

1.2

1.3

—

Acute upper respiratory infections

155

580

1.60

6.70

1.4

1.3

—

Acute bronchitis

362

1.95

6.69

1.3

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

378

1.93

6.67

1.4

1.3

—

Dorsalgia

140

449

1.65

6.66

1.3

—

Injuries to the hip and thigh

431

1.83

6.64

1.3

—

Immunodeficiencies

6.44

6.63

1.8

1.4

—

Migraine without aura

2.98

6.63

1.2

1.3

—

Peripheral arterial reconstruction

175

2.41

6.58

1.4

1.3

—

Varicose veins

421

1.78

6.57

1.4

1.3

—

Secondary uncertain malignant neoplasm

111

2.80

6.56

1.7

1.4

—

419

1.83

6.52

1.3

—

Peripheral artery operations in Hilmo

117

2.74

6.51

1.4

1.3

—

Other gastritis (incl. Duodenitis)

176

2.39

6.50

1.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

170

2.42

6.49

1.7

1.3

—

Focal epilepsy, strict definition

152

2.51

6.48

1.8

1.3

—

Pyothorax

6.20

6.47

1.4

—

Abnormal findings on diagnostic imaging of other body structures

101

2.88

6.45

1.3

1.4

—

Non-Hodgkin lymphoma, all

5.71

6.45

1.5

1.4

—

Leisure time condition

135

2.60

6.44

1.4

1.3

—

Vitamin B12 deficiency anaemia

3.14

6.43

1.6

1.3

—

Diabetes medication

148

539

1.60

6.42

1.4

1.3

—

Undetermined asthma

3.92

6.42

1.3

1.1

—

Acute posthaemorrhagic anaemia

7.43

6.41

1.2

1.3

—

Paroxysmal tachycardia

3.13

6.39

1.2

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2.77

6.38

1.5

1.2

—

Insulin, fast-acting or short human

321

2.00

6.36

1.4

—

Injuries to the head

161

610

1.57

6.35

1.4

1.3

—

Other pleural conditions

3.03

6.33

1.2

1.3

—

Migraine

246

2.03

6.33

1.1

1.3

—

Schizophrenia

3.03

6.33

1.8

1.5

—

Traumatic subdural haemorrhage

3.12

6.30

2.0

1.3

—

Campylobacter enteritis

9.32

6.29

1.0

—

Pneumonitis due to solids and liquids

3.17

6.28

1.5

1.4

—

Diabetes, varying definitions

142

511

1.61

6.28

1.4

1.3

—

Other and unspecified dermatitis

458

1.81

6.21

1.3

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

342

1.94

6.19

1.3

1.4

—

Diabetes mellitus

142

511

1.61

6.18

1.5

1.3

—

Unspecified misadventure during surgical and medical care

5.03

6.18

1.2

1.6

—

Solid cancers

112

385

1.71

6.17

1.4

1.3

—

Cholangitis (primary sclerosing, PSC)

3.97

6.16

2.3

1.3

—

Ascites

3.97

6.16

1.5

1.3

—

Chronic ulcer of skin, not elsewhere classified

3.53

6.15

1.4

—

Hypo-osmolality and hyponatraemia

155

2.44

6.14

1.2

—

Other viral diseases, not elsewhere classified, including avohilmo

168

2.37

6.08

1.4

1.3

—

Artificial joint re-operation

3.60

6.03

1.1

1.4

—

6-mercaptopurine

10.06

6.03

1.5

1.6

—

Coagulation defects, purpura and other haemorrhagic conditions

134

2.54

6.01

1.6

1.3

—

Cutaneous abscess, furuncle and carbuncle

189

2.28

6.00

1.4

1.3

—

Injuries to the thorax

434

1.82

6.00

1.2

1.4

—

Other symptoms and signs involving the circulatory and respiratory systems

3.88

5.98

2.5

1.3

—

Endometriosis ASRM stages 1,2

2.98

5.94

1.0

1.3

—

Alcohol use disorder, ICD-based

316

1.96

5.93

1.3

1.4

—

Acquired absence of limb

15.31

5.93

1.1

1.3

—

Gastroduodenal ulcer

241

2.11

5.93

1.4

1.3

—

Other disorders of kidney and ureter

2.85

5.92

1.4

—

Pneumonia due to Streptococcus pneumoniae

7.27

5.92

1.5

1.3

—

Other symptoms and signs involving the digestive system and abdomen

2.85

5.92

1.6

1.2

—

Bipolar affective disorders

2.85

5.92

1.1

1.4

—

Lung cancer and mesothelioma

3.03

5.88

1.3

1.1

—

Vascular diseases of the intestine

5.04

5.87

1.5

1.3

—

Type 2 diabetes

137

497

1.60

5.86

1.4

1.3

—

Respiratory insufficiency

5.00

5.85

1.2

1.1

—

Portal vein thrombosis

11.27

5.81

1.4

1.3

—

Hernia

136

571

1.58

5.79

1.2

1.3

—

Other mental disorders due to brain damage and dysfunction and to physical disease

2.87

5.77

1.1

1.4

—

Dermatitis and eczema

161

624

1.53

5.74

1.3

—

Other (not insulin) diabetes medications

140

521

1.58

5.73

1.4

1.3

—

Coxarthrosis [arthrosis of hip](FG)

327

1.79

5.73

1.2

1.3

—

Post-traumatic stress disorder

4.87

5.73

1.2

1.3

—

Disorders of lipoprotein metabolism and other lipidaemias

115

423

1.65

5.72

1.3

—

Cholelithiasis, broad definition with cholecystitis

127

527

1.60

5.72

1.4

1.3

—

Polyarthrosis

150

2.35

5.71

1.2

1.3

—

Mental and behavioural disorders due to alcohol

385

1.83

5.71

1.3

—

Biological medication for rheuma

2.83

5.66

1.5

1.4

—

Fracture of femur

270

1.97

5.62

1.2

1.3

—

Vitreous haemorrhage

3.19

5.58

1.3

1.4

—

Collagenous colitis

3.40

5.58

1.6

1.3

—

Other complications of surgical and medical care, not elsewhere classified

3.40

5.58

1.9

1.4

—

Sulfasalazine

170

2.30

5.57

1.3

—

Orchitis and epididymitis

3.40

5.57

1.1

1.4

—

Falls/tendency to fall

135

425

1.59

5.55

1.3

—

Finngen Rheumatological endpoints

128

454

1.60

5.54

1.4

1.3

—

Acute peritonitis

3.83

5.53

1.4

1.5

—

Malignant neoplasm of stomach

3.83

5.53

1.5

1.4

—

Thrombocytopenia, unspecified

3.82

5.53

1.8

1.5

—

Oesophageal varices

5.87

5.53

1.3

1.2

—

UC patients in KELA-register (code 208), prior to 1994

5.87

5.53

1.9

1.5

—

Personality disorders, excluding more controls

122

2.54

5.49

1.6

1.4

—

Unspecified dementia

2.76

5.48

1.4

1.3

—

Neurological diseases, wide definition

3.11

5.44

1.5

1.3

—

Neurotic, stress-related and somatoform disorders

119

511

1.60

5.42

1.2

1.4

—

Pneumonia derived septicemia

5.64

5.38

1.5

—

Other Crohn's disease

5.62

5.37

1.9

1.4

—

Solid cancers, including Hilmo

111

394

1.64

5.36

1.5

1.3

—

Striking against or struck by other objects

238

2.06

5.36

1.3

1.4

—

Acute upper respiratory infections of multiple and unspecified sites

108

483

1.63

5.32

1.4

1.3

—

D07AA Corticosteroids, weak (group I)

2.86

5.32

1.1

1.3

—

Abnormal serum enzyme levels

237

2.04

5.30

1.4

1.3

—

Antihypertensive medication - note that there are other indications

164

1.98

5.30

1.6

1.2

—

Intracerebral haemorrhage

107

2.62

5.30

1.4

1.3

—

Disorders of eyelid, lacrimal system and orbit

129

606

1.56

5.29

1.3

—

Ulcerative rectosigmoiditis

4.72

5.29

1.5

—

Migraine without aura and triptan purchases

2.92

5.29

1.1

1.3

—

Endometriosis of pelvic peritoneum

2.88

5.27

1.0

1.3

—

Atherosclerosis, excluding cerebral and coronary sclerosis

346

1.77

5.26

1.3

—

Disorders of lens

334

1.71

5.23

1.4

1.3

—

Status epilepticus

5.95

5.22

1.8

1.4

—

Gonarthrosis [arthrosis of knee](FG)

106

370

1.65

5.21

1.3

—

Alzheimer’s disease, strict definition

236

1.95

5.20

1.4

1.3

—

Alzheimer’s disease (Late onset)

224

1.99

5.20

1.4

1.3

—

Anxiety disorders

120

520

1.58

5.19

1.2

1.4

—

Anxiety (asthma-related co-morbidities)

308

1.80

5.18

1.2

1.3

—

Tumor necrosis factor alpha inhibitors

2.88

5.18

1.6

1.4

—

Corns and callosities

3.48

5.17

1.4

1.5

—

Osteoporosis with pathological fracture (FG)

2.95

5.14

1.5

1.4

—

Other female pelvic inflammatory diseases

109

2.57

5.12

1.3

—

Other/unspecified dorsalgia

308

1.89

5.11

1.2

1.3

—

Psoriasis vulgaris

121

2.48

5.10

1.2

1.4

—

Specific personality disorders

121

2.48

5.10

1.6

1.4

—

Hypothyroidism, drug reimbursement

5.24

5.10

1.9

1.1

—

Irritable bowel syndrome

158

2.28

5.09

1.2

—

Cholelithiasis

120

520

1.58

5.09

1.4

1.3

—

Transport accidents

287

1.86

5.08

1.3

1.4

—

Fracture of rib(s), sternum and thoracic spine

278

1.95

5.08

1.2

1.4

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

8.42

5.07

1.3

1.5

—

Complications of genitourinary prosthetic devices, implants and grafts

8.40

5.06

1.1

1.7

—

Right hemicolectomy

3.57

5.04

1.2

1.4

—

Substance use, excluding alcohol

104

2.60

5.04

1.9

1.4

—

Certain disorders involving the immune mechanism

134

2.39

5.03

1.6

1.3

—

Spinal stenosis

339

1.74

5.03

1.2

1.3

—

Pain in joint

257

1.79

5.03

1.1

1.4

—

Phobic anxiety disorders

3.27

4.99

1.2

1.5

—

2.69

4.99

1.6

1.4

—

Artificial opening status

4.71

4.99

2.5

1.4

—

Type 2 diabetes, strict (exclude DM1)

130

489

1.55

4.96

1.3

—

Other disorders of the musculoskeletal system and connective tissue

111

2.53

4.94

1.2

1.4

—

Suppurative and necrotic conditions of lower respiratory tract

4.35

4.93

1.4

1.5

—

Lichen simplex chronicus and prurigo

3.67

4.92

1.1

1.4

—

Psychiatric diseases

123

391

1.58

4.92

1.3

—

Paralytic ileus

6.04

4.91

1.7

1.5

—

Other arthrosis

299

1.75

4.91

1.3

—

Ulcerative proctitis

5.44

4.91

1.8

1.5

—

Lichen planus

2.67

4.90

1.2

1.4

—

Other cataract

269

1.82

4.88

1.2

1.3

—

Dermatitis due to substances taken internally

4.57

4.86

1.3

1.5

—

Carpal tunnel syndrome

452

1.67

4.85

1.3

—

Obesity due to excess calories

355

1.80

4.81

1.3

—

Disorders of lacrimal system

385

1.76

4.80

1.3

—

Use of anticholinesterases

321

1.76

4.79

1.3

—

N06DA Anticholinesterases

321

1.76

4.79

1.3

—

Type 2 diabetes, definitions combined

128

484

1.54

4.79

1.4

1.3

—

Pneumococcal septicemia

5.24

4.77

1.5

1.4

—

Hyperkalaemia

3.59

4.76

1.4

1.3

—

Heartburn

3.16

4.75

1.2

1.3

—

Invasive ventilation

3.42

4.74

1.6

1.4

—

Polycystic ovarian syndrome, consortium definition

326

1.65

4.72

1.3

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.79

4.70

1.4

—

Symptoms and signs concerning food and fluid intake

2.94

4.69

1.5

1.2

—

Postmenopausal osteoporosis with pathological fracture

3.03

4.67

1.5

1.4

—

Pacemaker

373

1.75

4.66

1.4

1.3

—

Other headache syndromes

307

1.85

4.66

1.2

1.3

—

Biguanides

133

531

1.51

4.64

1.4

1.3

—

Ventral hernia

198

2.07

4.63

1.3

1.4

—

COPD, hospital admissions 1, only main diagnosis

288

1.82

4.63

1.2

1.3

—

Disorders of calcium metabolism

4.30

4.62

2.3

1.3

—

Sequelae of injuries of lower limb

3.22

4.61

1.1

1.5

—

Endocarditis

6.15

4.60

1.1

1.4

—

Alcohol abuse, main dg, excluding more controls

2.76

4.60

1.2

1.4

—

Fibrosis and cirrhosis of liver

3.34

4.60

1.8

1.5

—

All anxiety disorders

333

1.72

4.60

1.1

1.4

—

Other specified and unspecified disorders of lens

14.25

4.59

1.0

1.2

—

Nonhereditary hypogammaglobulinemia

14.21

4.59

2.1

1.2

—

Disorders of adult personality and behaviour

153

2.22

4.57

1.5

1.4

—

Hypokalaemia

2.68

4.57

1.6

1.3

—

Other hammer toe(s) (acquired)

121

2.33

4.56

1.5

1.3

—

Fracture of lumbar spine and pelvis

226

1.99

4.54

1.4

1.3

—

Cervical disc disorders

276

1.89

4.51

1.2

1.3

—

Diaphragmatic hernia

312

1.83

4.50

1.1

1.4

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

452

1.65

4.49

1.3

—

Fall on same level involving ice and snow

521

1.63

4.48

1.3

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

3.16

4.48

1.6

1.5

—

Acute and transient psychotic disorders

3.15

4.48

1.9

1.4

—

Acquired haemolytic anaemia

6.72

4.47

2.0

1.3

—

Gout, idiopatic and unspecified

235

1.96

4.47

1.4

1.3

—

Conductive and sensorineural hearing loss

114

491

1.54

4.44

1.3

—

Coxarthrosis

282

1.72

4.44

1.2

1.3

—

Other nutritional deficiencies

483

1.63

4.43

1.3

—

Hernia of abdominal wall

387

1.73

4.43

1.3

—

Speech and linguistic disorders, excluding more controls

4.39

1.5

1.4

—

Poisoning by medicine

118

2.38

4.38

1.3

1.4

—

Somnolence, stupor and coma

4.67

4.37

1.6

1.4

—

Congenital malformations, deformations and chromosomal abnormalities

417

1.68

4.37

1.3

—

Superficial injury of abdomen, lower back and pelvis

106

2.46

4.37

1.6

1.3

—

Other salmonella infections

7.54

4.35

1.1

1.2

—

Malignant neoplasm of stomach, including Hilmo

3.21

4.33

1.5

1.3

—

Other diseases of pericardium

5.02

4.31

1.6

1.5

—

Inflammatory disorders of breast

4.26

4.31

1.1

1.4

—

Other viral hepatitis

5.02

4.31

2.8

1.5

—

Other dialysis

6.29

4.30

1.3

1.4

—

Osteonecrosis due to drugs

9.00

4.29

1.1

1.3

—

Primary Sclerosing Cholangitis, IBD and UDCA required

8.96

4.28

2.8

1.1

—

Poisoning by drugs, medicaments and biological substances

132

2.28

4.27

1.3

—

Varicose veins of other sites

4.13

4.20

1.1

1.4

—

Inflammatory diseases of female pelvic organs

326

1.66

4.20

1.2

1.3

—

Postmenopausal atrophic vaginitis

121

0.22

4.19

1.0

1.4

—

Use of disulfiram, acamprosate or naltrexone

3.86

4.19

1.1

1.5

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

4.83

4.18

1.7

1.4

—

Acute appendicitis, with complications

127

2.29

4.18

1.3

—

Other congenital malformations

3.42

4.17

1.1

1.4

—

Acidosis

6.98

4.17

1.8

1.3

—

Embolic stroke with flimmer

6.96

4.16

1.3

1.4

—

Haemolytic anaemias

5.27

4.14

2.0

1.3

—

Sensorineural hearing loss

109

475

1.53

4.14

1.3

—

Chronic viral hepatitis

5.26

4.14

2.9

1.5

—

Congenital malformations of genital organs

3.40

4.13

1.0

1.4

—

Other diseases of lip and oral mucosa

321

1.78

4.13

1.3

—

Other specified disorders of kidney and ureter

5.92

4.13

1.6

1.4

—

Dementia in Alzheimer disease

160

2.04

4.13

1.4

1.3

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

633

0.61

4.12

1.2

1.3

—

Pain (limb, back, neck, head abdominally)

278

1.62

4.12

1.4

—

Nontraumatic intracranial haemmorrhage

174

2.07

4.09

1.4

1.3

—

Other disorders of lacrimal gland

293

1.81

4.09

1.4

1.3

—

Disorders of continuity of bone

3.08

4.08

1.1

1.5

—

Migraine with aura

135

2.22

4.06

1.1

1.2

—

Other viral hepatitis, including avohilmo

4.63

4.05

2.7

1.5

—

Gastric ulcer

155

2.13

4.04

1.3

1.4

—

Gonarthrosis

318

1.60

4.01

1.3

—

Herpesviral [herpes simplex] infections

2.76

4.01

1.5

1.4

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

2.76

4.01

1.6

1.2

—

Rotator cuff syndrome

386

1.59

4.01

1.2

1.4

—

Viral hepatitis

4.21

4.01

2.6

1.6

—

Primary coxarthrosis, bilateral

288

1.81

4.00

1.1

1.4

—

Other appendicitis

3.90

3.99

1.4

—

Follow-up examination after treatment for malignant neoplasms

2.67

3.98

1.4

1.3

—

Other salmonella infections, including avohilmo

6.45

3.98

1.1

—

Other specific joint derangements/joint disorders

363

1.58

3.98

1.1

1.3

—

Other blood glucose lowering drugs, excl. Insulins

130

2.24

3.98

1.5

1.4

—

Shoulder lesions

106

415

1.53

3.97

1.2

1.4

—

Sequelae of injuries of upper limb

3.03

3.96

1.4

1.5

—

Alcohol abuse, main dg

2.53

3.95

1.2

1.5

—

Depression medications

2.96

3.94

1.1

1.3

—

Other disorders of white blood cells

4.46

3.93

1.4

1.3

—

Cough

283

1.78

3.92

1.3

—

Bronchitis, not specified as acute or chronic

3.13

3.92

1.5

1.4

—

Type 2 diabetes, definitions combined, including avohilmo

125

490

1.47

3.91

1.4

1.3

—

Cerebral palsy and other paralytic syndromes

2.72

3.91

1.3

1.5

—

Senile cataract

308

1.62

3.91

1.4

1.3

—

Personality disorders

144

2.16

3.91

1.6

1.4

—

Other and unspecified disorders of skin and subcutaneous tissue

3.27

3.90

1.0

1.4

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

3.27

3.90

1.7

1.6

—

Unspecified/other endometriosis

3.27

3.90

1.1

1.3

—

Speech and linguistic disorders

3.28

3.89

1.5

1.3

—

Caries of enamel

600

0.58

3.88

1.3

—

Endocrine, nutritional and metabolic diseases

277

1.60

3.88

1.7

1.2

—

Disorders of parathyroid gland

196

1.97

3.88

1.3

1.4

—

Mental retardation, wide definition

4.76

3.84

1.2

1.3

—

ILD-related respiratory insufficiency

5.30

3.83

2.0

1.6

—

Gingival hyperplasia

5.29

3.83

1.9

1.4

—

Hepatic failure, not elsewhere classified

5.29

3.83

2.0

1.5

—

Parkinson's disease, excluding more controls

2.63

3.81

1.4

1.3

—

Neuralgia and neuritis, unspecified

4.30

3.81

1.2

1.5

—

Spirochaetal infections, other/unspecified, including avohilmo

256

0.31

3.81

1.0

1.3

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

4.30

3.81

2.9

1.5

—

Ulcer of oesophagus

3.07

3.80

1.3

1.4

—

Other and unspecified myopathies

2.61

3.80

1.4

—

Chronic pancreatitis

2.54

3.79

1.0

1.4

—

Conduction disorders

192

1.88

3.78

1.3

—

Postprocedural disorders of ear and mastoid process, not elsewhere classified

12.20

3.78

1.0

—

Visual disturbances

429

1.63

3.77

1.3

—

Adult respiratory distress syndrome

12.12

3.77

2.0

1.0

—

Other diseases of peritoneum

4.60

3.74

1.2

1.6

—

Other congenital malformations, including avohilmo

2.73

3.74

1.1

1.3

—

Diabetic nephropathy, excluding more controls

102

2.24

3.73

1.6

1.5

—

Exposure to unspecified factor

137

654

1.42

3.71

1.4

1.3

—

Mental retardation, excluding more controls

5.81

3.71

1.2

1.3

—

Embedded teeth, including avohilmo

3.60

3.69

1.3

1.4

—

Cirrhosis of liver, NAS

3.84

3.69

1.8

1.5

—

Viral hepatitis, including avohilmo

3.83

3.69

2.6

1.5

—

Lyme disease, including avohilmo

253

0.32

3.67

1.0

1.3

—

Lyme disease

253

0.32

3.67

1.0

1.3

—

Spondylopathies

105

413

1.50

3.65

1.3

—

Flat foot [pes planus] (acquired)

2.69

3.65

1.7

1.3

—

Cyst of kidney

3.12

3.65

1.2

1.5

—

External causes of morbidity and mortality

210

1.67

3.63

1.3

1.4

—

Migraine with aura and triptan purchases

2.61

3.63

1.1

1.3

—

Acute alcohol intoxication, ICD10

129

2.17

3.62

1.2

1.5

—

Visual disturbances and blindness

480

1.58

3.62

1.3

—

Other arthritis (FG)

232

1.86

3.62

1.4

1.3

—

Deforming dorsopathies

204

1.91

3.60

1.4

—

Lumbar disc prolapse

399

1.56

3.60

1.3

1.4

—

Fracture of shoulder and upper arm

335

1.70

3.59

1.1

1.4

—

Parkinson's disease, strict definition, excluding more controls

2.61

3.59

1.4

1.3

—

Disorders of choroid and retina

116

557

1.46

3.59

1.2

1.3

—

Coxarthrosis, primary

496

1.52

3.58

1.2

1.3

—

Phlebitis and thrombophlebitis (not including DVT)

170

2.00

3.57

1.3

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

2.66

3.56

1.2

1.4

—

Other retinal disorders

496

1.50

3.55

1.3

—

Appendicitis, broad definition

553

1.51

3.54

1.2

1.3

—

Rheumatism, unspecified

2.45

3.54

1.3

—

Other spirochaetal diseases, including avohilmo

263

0.34

3.53

1.0

1.3

—

Familial hypercholesterolemia

124

2.18

3.53

1.4

1.3

—

Injuries to the knee and lower leg

157

612

1.39

3.53

1.3

—

Amputation of ankle bones

5.34

3.51

1.3

1.4

—

Acute generalized exanthematous pustulosis

4.25

3.50

1.3

1.4

—

Immunodeficiency with predominantly antibody defects

6.19

3.50

2.0

1.4

—

Xerosis cutis

10.07

3.50

1.0

1.3

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

250

1.80

3.47

1.4

—

Other diseases of pancreas

2.89

3.46

1.2

1.5

—

Diabetic retinopathy, strict definition

134

2.06

3.43

1.3

1.5

—

Personal history of other diseases and conditions

2.87

3.42

1.5

1.2

—

Fracture of skull and facial bones

166

1.99

3.42

1.5

1.3

—

Conjunctivitis (acute, non atopic)

193

1.91

3.42

1.4

1.3

—

Other spirochaetal diseases

258

0.35

3.40

1.0

1.3

—

Lymphoid leukaemia

3.53

3.40

1.8

1.3

—

Methotrexate

2.39

3.38

1.3

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.76

3.38

1.0

1.4

—

Familial hypercholesterolemia, with ischemic heart disease

2.58

3.38

1.4

1.3

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

202

1.88

3.37

1.1

1.3

—

Glucagon-like peptide-1 (GLP-1) analogues

202

1.88

3.37

1.1

1.3

—

Respiratory conditions due to other external agents

7.05

3.37

1.3

—

Hypothyroidism (congenital or acquired)

2.88

3.36

1.5

1.3

—

Dorsopathies

127

450

1.43

3.36

1.3

—

Neoplasms

271

1.57

3.34

1.7

1.2

—

Nephrotic syndrome

5.74

3.34

2.1

1.4

—

Agoraphobia

5.74

3.34

1.3

1.6

—

Diseases of appendix

559

1.49

3.33

1.2

1.3

—

Hypertensive heart and/or renal disease

125

1.99

3.33

1.4

1.2

—

Other specified/unspecified arthritis

196

1.89

3.32

1.4

1.3

—

Hyperparathyroidism

180

1.93

3.31

1.2

1.4

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

183

1.91

3.31

1.2

1.3

—

Mood [affective] disorders

131

597

1.41

3.31

1.2

1.4

—

Contact with machinery

2.62

3.30

1.1

1.4

—

Acute gastritis

2.92

3.29

1.1

1.4

—

Weight loss

2.47

3.29

1.5

1.4

—

Abnormal weight loss

2.54

3.29

1.6

1.5

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

3.94

3.28

1.3

1.5

—

Barrett oesophagus

3.94

3.28

1.1

1.5

—

Medical observation and evaluation for suspected diseases and conditions

233

1.60

3.28

1.6

1.3

—

Acute myeloid leukaemia, helper endpoint

8.65

3.27

1.5

1.3

—

Acute myeloid leukaemia, including Hilmo

8.65

3.27

1.5

1.3

—

Acute myeloid leukaemia

8.65

3.27

1.5

1.3

—

Colitis, primary sclerosing

8.65

3.27

3.2

1.0

—

Intussusception

8.62

3.26

1.5

1.9

—

Diseases of the myoneural junction and muscle

2.30

3.26

1.3

1.4

—

Mood disorders

131

598

1.40

3.25

1.2

1.4

—

Rare circulating lymphoid malignancy, including Hilmo

4.76

3.24

1.6

1.4

—

Pain associated with micturition

2.34

3.23

1.1

1.4

—

Soft tissue disorders

129

468

1.41

3.21

1.2

1.4

—

Abnormalities of gait and mobility

103

2.24

3.21

1.6

1.4

—

Later onset COPD

246

1.70

3.20

1.2

1.3

—

Urinary track infection

187

1.66

3.19

1.3

1.2

—

Intestinal malabsorption

4.18

3.19

1.7

1.5

—

Problems related to social environment

5.36

3.19

1.1

—

Cystitis

102

414

1.47

3.19

1.3

—

Abnormal results of function studies

2.86

3.19

1.2

1.5

—

Asthma and opportunity respiratory infection

3.81

3.18

1.5

1.6

—

Convergent concomitant strabismus

3.80

3.18

1.5

1.4

—

Disorders of vestibular function (Vertigo)

422

1.57

3.17

1.3

—

False labour

2.07

3.16

1.1

1.2

—

Type 1 diabetes, wide definition, subgroup 1

130

2.08

3.16

1.2

1.3

—

Disorders of tooth development and eruption

2.26

3.16

1.4

—

Specific development disorders of speech and language

3.51

3.15

1.4

1.2

—

Other diseases of liver

117

2.14

3.15

1.3

1.4

—

Sulfonylureas

293

1.63

3.15

1.5

1.3

—

Use of donepezil

246

1.75

3.14

1.4

1.3

—

Obesity and other hyperalimentation

475

1.52

3.14

1.3

—

Periapical abscess

357

1.63

3.14

1.4

1.3

—

Diseases of inner ear

484

1.52

3.13

1.3

—

Other metabolic disorders

2.41

3.13

1.6

1.2

—

Thyroiditis, ILD-related definition

2.63

3.13

1.1

1.3

—

Effects of foreign body entering through natural orifice

172

1.92

3.13

1.5

1.4

—

Hydronephrosis

2.54

3.12

1.2

1.3

—

Urticaria and erythema

259

1.74

3.12

1.4

1.3

—

Myelodysplastic syndrome, including Hilmo

4.52

3.11

1.2

1.6

—

Other and unspecified tonsillitis

130

1.98

3.11

1.2

1.3

—

Combinations of oral blood glucose lowering drugs

223

1.80

3.09

1.4

1.3

—

Mental retardation

4.48

3.08

1.2

—

Spermatocele

2.81

3.08

1.2

1.4

—

L04AC Interleukin inhibitors

3.68

3.08

1.2

1.4

—

Outcome of delivery

0.00

3.08

0.0

1.1

—

Systemic connective tissue disorders

313

1.66

3.07

1.2

1.3

—

Polyarteritis nodosa and related conditions

7.57

3.06

1.3

—

Bronchiectasis

2.69

3.05

1.3

1.4

—

Myeloid leukaemia

5.03

3.05

1.5

1.4

—

Open wound of head

463

1.52

3.05

1.3

—

Other disorders of ear

121

558

1.40

3.04

1.3

—

Other sleep disorders

2.44

3.04

1.2

1.3

—

Hypothyroidism, levothyroxine purchases

2.80

3.04

1.5

1.3

—

Hypothyroidism and >3 levothyroxin purchases

2.80

3.04

1.5

1.3

—

Family history of malignant neoplasm

2.59

3.04

1.4

1.2

—

Injuries to unspecified part of trunk, limb or body region

2.51

3.03

1.8

1.4

—

Acute pancreatitis (for exclusion)

153

1.96

3.03

1.5

1.3

—

Anaemia in chronic diseases classified elsewhere

5.87

3.02

1.6

1.3

—

Disorders of speech understanding and production

3.94

3.02

1.5

1.3

—

Other systemic involvement of connective tissue (FG)

206

1.81

3.02

1.2

1.3

—

Asthma mixed form (mode), excluding more controls

5.84

3.02

2.3

1.0

—

Hyperplasia of prostate

147

1.76

3.01

1.4

1.3

—

Adenocarcinoma and papillary adenocarcinoma of stomach

4.31

2.99

1.2

1.5

—

Arthrosis

341

1.48

2.98

1.4

1.3

—

Colitis, primary sclerosing, strict definition

10.10

2.98

2.4

1.0

—

Pain, not elsewhere classified

175

1.89

2.98

1.3

1.2

—

Hypertensive Heart Disease

120

1.96

2.98

1.4

1.2

—

Irregular menses

229

1.67

2.96

1.2

—

Cholecystitis

127

2.05

2.96

1.5

1.3

—

Cellulitis

162

1.92

2.93

1.7

1.3

—

Type 1 diabetes

169

1.89

2.92

1.3

—

Benign neoplasm of thyroid gland

4.73

2.92

1.5

—

Extreme obesity with alveolar hypoventilation

4.72

2.92

1.3

1.5

—

Sciatica+with lumbago

377

1.55

2.91

1.3

—

Ovarian cyst

147

1.75

2.91

1.2

1.3

—

Vascular syndromes of brain in cerebrovascular disorders

3.45

2.90

1.5

1.3

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

3.45

2.89

2.0

1.5

—

Symptoms and signs involving the skin and subcutaneous tissue

626

1.43

2.89

1.3

—

Factors influencing health status and contact with health services

1.98

2.89

1.5

1.2

—

Infective dermatitis

2.37

2.89

1.3

1.5

—

Acute pancreatitis

156

1.93

2.88

1.5

1.3

—

Fissure and fistula of anal and rectal regions

149

1.95

2.88

1.4

1.3

—

Superficial injury of hip and thigh

149

1.95

2.88

1.2

1.4

—

Acute appendicitis

524

1.47

2.88

1.2

1.3

—

Background retinopathy and retinal vascular changes

5.42

2.87

1.4

1.3

—

Left hemicolectomy

5.42

2.87

1.3

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

6.71

2.87

3.2

1.2

—

Faecal incontinence

2.59

2.87

1.5

1.2

—

Other infectious diseases, including avohilmo

2.51

2.87

1.8

1.4

—

Coeliac disease

2.50

2.86

1.7

1.3

—

Necrosis of pulp, including avohilmo

440

1.53

2.86

1.2

1.3

—

Extrapyramidal and movement disorders

359

1.59

2.85

1.3

—

Other diseases of intestine

2.19

2.82

1.3

—

Car occupant injured in other and unspecified transport accidents

116

2.07

2.82

1.4

—

Disorders of psychological development

2.58

2.80

1.5

1.3

—

Basal cell carcinoma

258

1.59

2.80

1.3

—

Disorders of sclera, cornea, iris and ciliary body

472

1.51

2.80

1.4

1.3

—

Other diseases of spinal cord

4.47

2.79

1.1

1.5

—

Non-selective monoamine reuptake inhibitors

301

1.63

2.79

1.2

1.3

—

Cervicalgia

151

1.92

2.79

1.2

1.3

—

Alcohol dependence

194

1.81

2.78

1.2

1.3

—

Obesity

475

1.49

2.77

1.3

—

Asthma and allergy, excluding more controls

3.29

2.76

1.2

1.1

—

8.44

2.76

1.4

1.0

—

Colitis due to radiation

8.42

2.75

2.6

1.3

—

Isolated proteinuria with specified morphological lesion

8.41

2.75

1.8

1.3

—

Seropositive rheumatoid arthritis

201

1.78

2.75

1.2

1.3

—

Lichen planus, including avohilmo

145

1.93

2.74

1.2

1.3

—

Valvular operations

104

2.12

2.73

1.4

1.3

—

Superficial injury of head

217

1.75

2.73

1.2

1.3

—

Acute myeloid leukaemia and myelodysplastic syndromes

5.03

2.73

1.4

1.6

—

Chronic hepatitis, not elsewhere classified

5.02

2.73

1.1

1.9

—

Colorectal cancer, including Hilmo

209

1.74

2.72

1.4

1.3

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

2.71

1.3

1.5

—

Diseases of the eye and adnexa

289

1.47

2.70

1.5

1.3

—

Tuberculosis of other organs

6.04

2.70

1.3

—

Other disorders of binocular movement

6.03

2.70

1.8

1.2

—

Other and unspecified urticaria

125

2.00

2.70

1.3

—

Other hearing loss

307

1.61

2.69

1.2

1.3

—

Benign paroxysmal vertigo

256

1.68

2.69

1.3

—

Acute lymphadenitis

3.46

2.69

1.1

1.3

—

Cervicobrachial syndrome

139

1.94

2.69

1.4

1.3

—

Rheumatoid arthritis

239

1.67

2.69

1.2

1.3

—

Obsessive-compulsive disorder

3.45

2.68

1.1

1.3

—

Persons encountering health services for examination and investigation

233

1.53

2.68

1.5

1.3

—

Asthma and allergy

3.20

2.68

1.2

1.1

—

Amblyopia ex anopsia

3.76

2.67

1.7

1.2

—

Idiopathic gout

2.28

2.67

1.4

—

Other external causes of accidental injury

319

1.45

2.66

1.2

1.4

—

Benign neoplasm: Colon, unspecified

227

1.72

2.65

1.5

1.3

—

Corneal ulcer

119

2.02

2.65

1.3

—

Injury, poisoning and certain other consequences of external causes

174

1.61

2.65

1.4

1.3

—

Impingement syndrome of shoulder

154

1.89

2.64

1.3

1.4

—

Cardiac murmurs and other cardiac sounds

2.57

2.64

1.4

1.2

—

Type 1 diabetes, wide definition

147

1.90

2.63

1.3

—

Thiazolidinediones

2.21

2.63

1.6

1.3

—

Hydrocele

2.21

2.63

1.2

1.4

—

Benign neoplasm: Stomach

2.39

2.63

1.6

1.4

—

Sicca syndrome [Sjögren]

2.55

2.61

1.1

1.3

—

Unspecified kidney failure

2.16

2.60

2.6

1.3

—

Crohn disease (strict definition, require KELA, min 2 HDR)

3.34

2.60

2.1

1.5

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

4.69

2.60

1.4

1.1

—

Mental and behavioural disorders due to opioids

4.68

2.60

4.1

1.1

—

Asthma mixed form (mode)

4.68

2.59

2.3

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

629

0.67

2.59

1.1

1.4

—

Haemorrhoids and perianal venous thrombosis

257

1.66

2.59

1.1

1.3

—

Stenosis and insufficiency of lacrimal passages

2.30

2.57

1.1

1.3

—

Generalized skin eruption due to drugs and medicaments

3.61

2.57

1.3

1.4

—

Myocardial infarction, unclassifiable

224

1.68

2.57

1.2

1.3

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

409

1.51

2.57

1.3

—

Oesophageal obstruction

4.02

2.57

1.3

1.4

—

Insulin, fast-acting (human)

2.19

2.56

1.2

1.5

—

Chronic myeloproliferative disease

7.20

2.55

1.2

1.3

—

Other disorders of binocular vision

7.20

2.55

1.0

—

Eosinophilia

7.19

2.55

1.6

1.1

—

Tuberculosis of other organs, strict

5.48

2.54

1.3

1.5

—

Tuberculosis of other organs, strict, including avohilmo

5.48

2.54

1.3

1.5

—

Gout, strict definition

178

1.80

2.54

1.3

—

Aortic valve malfunction, age under 60 years

2.86

2.54

1.3

1.6

—

Other embolism and thrombosis

2.13

2.54

1.4

—

Visual field defects

2.43

2.53

1.3

—

Diseases of male genital organs

185

1.58

2.53

1.4

1.5

—

Fracture of lower leg, including ankle

466

1.47

2.53

1.4

1.3

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

264

1.54

2.53

1.3

—

Emotionally unstable personality disorder

2.60

2.53

1.0

1.3

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

2.42

2.52

1.3

1.4

—

Myocardial infarction, with ST-elevation

164

1.83

2.52

1.7

1.4

—

Crohn disease (strict definition, require KELA)

3.23

2.51

2.1

1.5

—

Congenital malformations of eye, ear, face and neck

3.23

2.51

1.1

1.5

—

Disorders of synovium and tendon

381

1.49

2.51

1.3

1.4

—

Accidents

319

1.43

2.50

1.3

1.4

—

Ulcer of lower limb, not elsewhere classified

136

1.92

2.49

1.5

1.4

—

Spondylolisthesis/Spondylolysis

122

1.97

2.49

1.3

—

Other disorders of nervous system

2.98

2.48

1.5

—

Conjunctivitis (acute, non atopic), including avohilmo

636

0.69

2.48

1.2

1.3

—

Use of antiglaucoma preparations and miotics

2.32

2.48

1.1

1.5

—

Other and unspecified erythematous conditions

4.39

2.47

1.4

—

Coxarthrosis, primary, with hip surgery

427

1.48

2.47

1.2

1.3

—

Pruritus

2.20

2.47

1.4

—

Lichen simplex chronicus

3.83

2.46

1.1

1.4

—

Lesion of radial nerve

3.82

2.46

1.8

1.3

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

3.82

2.46

1.4

—

Malignant neoplasm of skin

276

1.52

2.46

1.3

—

Colorectal cancer

201

1.72

2.45

1.4

—

Insomnia

604

0.67

2.43

1.0

1.4

—

Embedded and impacted teeth

110

1.92

2.43

1.3

1.5

—

Oesophagitis

3.13

2.43

1.1

1.5

—

Undefined dementia

133

1.88

2.42

1.4

1.3

—

Reimbursement for rheumatic diseases

502

1.45

2.41

1.4

1.3

—

Appendectomy

488

1.44

2.40

1.4

1.3

—

Diseases of spleen

5.03

2.40

1.3

1.4

—

Urethritis and urethral syndrome

5.02

2.40

1.8

1.4

—

Mild mental retardation

5.02

2.40

1.3

1.0

—

Superficial injury of lower leg

189

1.75

2.40

1.5

1.4

—

Polymyalgia rheumatica

124

1.94

2.39

1.3

1.4

—

Hypercalcemia

3.35

2.39

1.6

1.5

—

Abnormalities of heart beat

272

1.61

2.38

1.4

1.3

—

Seborrhoeic dermatitis

2.35

2.38

1.2

1.5

—

Duodenal ulcer

2.12

2.38

1.5

1.3

—

Cauda equina syndrome

6.30

2.37

1.0

1.3

—

Marginal zone B-cell lymphoma, including Hilmo

6.29

2.37

1.6

1.5

—

Infliximab

6.28

2.37

1.0

—

Other infectious diseases

2.42

2.36

1.9

1.4

—

Generalized epilepsy

3.65

2.36

1.8

1.3

—

Benign neoplasm: Skin of lower limb, including hip

4.14

2.36

1.3

1.5

—

Ulcerative enterocolitis

4.13

2.36

2.1

1.4

—

Other erythematous conditions

4.13

2.36

1.4

1.6

—

Brachial plexus disorders

2.61

2.35

1.0

1.3

—

Nonalcoholic fatty liver disease

2.50

2.35

1.4

—

Fracture of foot, except ankle

168

1.79

2.35

1.3

1.4

—

Salpingitis and oophoritis

104

2.02

2.35

1.2

1.3

—

Follicular cysts of skin and subcutaneous tissue

125

1.92

2.34

1.4

—

Umbilical hernia

213

1.69

2.34

1.4

1.3

—

Cardiomyopathy

118

1.95

2.34

1.6

1.3

—

Glaucoma suspect

338

1.54

2.32

1.2

1.4

—

Thyrotoxicosis

191

1.73

2.32

1.3

—

Myalgia

169

1.78

2.31

1.1

1.3

—

Basal cell carcinoma, including Hilmo

264

1.51

2.31

1.4

1.3

—

Benign neoplasm of other and ill-defined parts of digestive system

140

1.86

2.31

1.5

1.3

—

Otitis externa, unspecified

2.31

1.0

1.5

—

Femoral hernia

3.23

2.30

1.2

1.5

—

Scabies

3.22

2.30

1.0

1.4

—

Diseases of the ear and mastoid process

137

522

1.32

2.30

1.3

—

Coronary artery bypass grafting

151

1.72

2.30

1.5

1.3

—

Alcoholic liver disease

2.38

2.29

1.3

1.6

—

Hypopituitarism

2.95

2.28

1.2

1.5

—

Diabetic maculopathy, excluding more controls

2.23

2.27

1.3

—

Acute alcohol intoxication

185

1.73

2.27

1.2

1.3

—

Excessive, frequent and irregular menstruation

152

1.62

2.27

1.3

—

Elevated blood glucose level

2.56

2.27

1.2

1.5

—

Volvulus

3.91

2.25

1.1

1.3

—

Superficial injury of thorax

106

1.98

2.25

1.2

1.4

—

Primary gonarthrosis, bilateral

421

1.43

2.23

1.3

—

Benign neoplasm: Colon

497

1.42

2.23

1.5

1.3

—

Amputation of thigh

3.12

2.22

1.8

1.3

—

Psoriasis

209

1.68

2.22

1.3

—

Diabetic neuropathy

106

1.98

2.22

1.4

—

Mature T/NK-cell lymphomas, hilmo

5.60

2.22

1.8

1.2

—

Obstructive hydrocephalus

5.59

2.21

2.2

1.2

—

Charcot foot

5.59

2.21

2.0

1.1

—

Certain zoonotic bacterial diseases

5.58

2.21

1.2

1.3

—

Sleep disorders

618

0.69

2.21

1.0

1.4

—

Other superficial mycoses

5.58

2.21

1.4

1.0

—

Selective serotonin reuptake inhibitors

118

460

1.33

2.21

1.2

1.4

—

Chromosomal abnormalities, not elsewhere classified

5.57

2.21

1.4

1.2

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

217

1.66

2.21

1.2

1.3

—

Embolic stroke

2.69

2.20

1.4

—

Zoster [herpes zoster], including avohilmo

465

1.43

2.19

1.3

—

AV-block

146

1.76

2.19

1.3

—

Emphysema

2.51

2.18

1.0

1.5

—

Arterial embolism and thrombosis

2.51

2.18

1.4

1.5

—

Other and unspecified injuries of wrist and hand

3.34

2.18

1.0

1.5

—

Speech therapy

212

0.42

2.17

2.0

1.3

—

Diabetic retinopathy, excluding more controls

127

1.68

2.17

1.3

1.4

—

Cholecystectomy

580

1.36

2.17

1.3

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

173

1.74

2.16

1.2

1.3

—

Benign neoplasm of colon, rectum, anus and anal canal

528

1.38

2.15

1.5

1.3

—

Drug-induced cataract

4.31

2.15

1.3

1.5

—

Use of ropinirole

3.70

2.15

1.7

1.5

—

Sequelae of injuries of head

3.01

2.14

3.6

1.6

—

Other and unspecified local infections of skin and subcutaneous tissue

2.30

2.14

1.1

1.5

—

Chronic gastritis

250

1.60

2.14

1.3

—

Excessive earwax

588

0.65

2.14

1.4

1.3

—

Other aneurysm

2.63

2.14

1.1

1.5

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

2.79

2.13

1.2

1.4

—

Schizoaffective disorder

2.78

2.13

1.2

1.4

—

Gonarthrosis,primary

116

529

1.32

2.12

1.3

—

Acute pharyngitis

2.22

2.12

1.2

1.3

—

Fracture at wrist and hand level

274

1.57

2.10

1.1

1.4

—

Inflammatory diseases of the central nervous system

2.45

2.10

1.8

1.5

—

Persons encountering health services in other circumstances, wide

644

0.74

2.10

1.4

1.3

—

Depression

112

566

1.32

2.10

1.2

1.3

—

Other/unspecified rheumatoid arthritis

102

1.96

2.10

1.2

1.4

—

Complications of other internal prosthetic devices, implants and grafts

3.21

2.09

1.1

1.6

—

Tonsillectomy and adenotomy

250

1.50

2.09

1.2

1.4

—

Postpartum care and examination

2.30

2.08

1.0

1.1

—

Diabetic nephropathy

158

1.75

2.08

1.6

1.5

—

Disorders of skin appendages

370

1.48

2.08

1.3

—

Acute nephritic syndrome

5.02

2.07

1.2

1.3

—

Vascular dementia (mixed)

5.02

2.07

1.2

1.3

—

Pediculosis, acariasis and other infestations

2.91

2.07

1.0

1.5

—

Tooth eruption problems

2.20

2.07

1.4

1.3

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

2.71

2.07

1.1

1.4

—

Other disorders involving the immune mechanism, not elsewhere classified

3.51

2.05

1.4

—

Malignant neoplasm of liver and intrahepatic bile ducts

3.51

2.05

1.1

1.5

—

Arthropathies in other diseases classified elsewhere

3.51

2.05

1.7

1.4

—

Panniculitis affecting regions of neck and back

3.51

2.05

1.1

1.5

—

Diabetic retinopathy

218

1.51

2.05

1.3

1.4

—

Lesion of ulnar nerve

2.03

2.05

1.4

1.3

—

Arthropathies

102

383

1.35

2.05

1.4

1.3

—

Subarachnoid haemorrhage

2.18

2.04

1.2

1.4

—

Panic disorder

2.18

2.04

1.3

1.4

—

Chronic lymphocytic leukaemia

4.02

2.04

2.0

1.4

—

Chronic lymphocytic leukaemia, helper endpoint

4.02

2.04

2.0

1.4

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

4.02

2.04

2.0

1.4

—

Female genital prolapse

133

1.63

2.04

1.3

1.4

—

Chronic sinusitis

341

1.49

2.03

1.1

1.3

—

Chronic diseases of tonsils and adenoids

390

1.37

2.03

1.2

1.3

—

Glaucoma

479

1.38

2.03

1.2

1.3

—

Fibromyalgia

2.40

2.02

1.2

—

Other/unspecified seropositive rheumatoid arthritis

223

1.62

2.01

1.2

1.3

—

Other intracranial haemorrhages

3.09

2.01

1.1

1.4

—

Vitamin deficiency

3.08

2.01

1.0

1.5

—

Vitamin deficiency, wide

3.08

2.01

1.0

1.5

—

Abnormal findings on diagnostic imaging of central nervous system

3.08

2.01

1.4

1.5

—

Osteomyelitis

2.64

2.00

1.6

1.5

—

Psychotic depression

2.82

2.00

1.2

1.4

—

Trigger finger

1.96

1.99

1.2

1.4

—

Crowding of teeth, including avohilmo

2.87

1.99

1.4

1.3

—

Dental operations

274

1.41

1.99

1.4

1.3

—

Delivery, wide proxy

189

0.53

1.98

1.3

—

Seropositive rheumatoid arthritis, wide

224

1.61

1.98

1.2

1.3

—

Deep endometriosis

2.28

1.97

1.1

1.3

—

Occupational exposure to risk-factors

3.35

1.96

1.3

1.4

—

Malignant neoplasm of oesophagus, including Hilmo

3.34

1.96

1.4

1.6

—

Other and unspecified disorders of white blood cells

3.34

1.96

1.3

1.4

—

Noise effects on inner ear

3.34

1.96

1.7

1.3

—

Unspecified abortion

3.34

1.96

1.0

1.4

—

Hypoplasia of dental enamel , including avohilmo

3.85

1.96

1.5

1.0

—

Generalized anxiety disorder

2.08

1.95

1.0

1.4

—

Molar incisor enamel hypoplasia

3.83

1.95

1.5

1.0

—

Gonarthrosis, primary, with knee surgery

435

1.38

1.94

1.3

—

Acute laryngitis and tracheitis

2.46

1.94

1.4

1.3

—

Other and unspecified hydrocephalus

4.57

1.94

4.6

1.0

—

Other skin changes

179

1.68

1.94

1.2

1.3

—

Viral encephalitis, not elsewhere classified/unspecified

4.57

1.94

1.0

1.3

—

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

4.57

1.94

1.0

1.3

—

Erythema multiforme

4.56

1.94

1.2

1.3

—

Congenital malformations of the respiratory system, including avohilmo

4.56

1.94

2.2

1.4

—

Superficial injury of ankle and foot

2.19

1.94

1.0

1.4

—

L01XX Other antineoplastic agents

2.57

1.94

2.2

1.4

—

Other encephalitis

3.76

1.93

2.2

1.3

—

Haemorrhage, not elsewhere classified

2.97

1.93

1.4

1.2

—

Hodgkin lymphoma, hilmo

3.76

1.93

1.5

1.1

—

Encephalitis

3.76

1.93

2.2

1.3

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

3.76

1.93

1.7

1.6

—

Redundant prepuce, phimosis and paraphimosis

132

1.79

1.93

1.3

1.6

—

Malignant neoplasm of skin, including Hilmo

278

1.45

1.93

1.3

—

Other pulmonary heart/vessel disease

2.74

1.93

1.2

1.4

—

Use of rivastigmine

202

1.63

1.92

1.3

—

Assault

2.12

1.92

1.5

1.7

—

Diplopia

1.92

1.90

1.4

—

Disturbances of skin sensation

188

1.65

1.90

1.3

1.2

—

Operations 2 for CAVS

334

1.47

1.89

1.3

—

Calcific aortic valvular stenosis, diagnosis (helper)

334

1.47

1.89

1.3

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

110

659

1.30

1.89

1.3

—

Persistent mood disorders

128

1.80

1.89

1.1

1.4

—

Deep bite

2.34

1.88

1.4

—

Colonic or urogenital fistula

204

1.62

1.88

1.5

1.3

—

Pericarditis

3.19

1.88

1.1

1.5

—

Other local infections of skin and subcutaneous tissue

2.16

1.87

1.1

1.5

—

Calcific aortic valvular stenosis, operated

335

1.47

1.87

1.3

—

Calcific aortic valvular stenosis

335

1.47

1.87

1.3

—

Statin medication

300

1.39

1.87

1.4

1.3

—

Calcific aortic valvular stenosis, including rheumatic fever

335

1.46

1.86

1.3

—

Congenital malformations of the urinary system, including avohilmo

2.65

1.86

1.8

1.6

—

Arterial embolism and thrombosis of lower extremity artery

2.87

1.86

1.5

1.4

—

Crohn's disease of small intestine

2.86

1.86

2.4

1.4

—

Other systemic involvement of connective tissue

244

1.56

1.86

1.2

1.3

—

Seropositive rheumatoid arthritis, strict definition

107

1.87

1.85

1.3

1.4

—

Benign neoplasm: Choroid

2.40

1.85

1.2

1.5

—

Benign neoplasm of eye and adnexa

2.03

1.85

1.1

1.4

—

Primary hyperparathyroidism

1.98

1.84

1.2

1.3

—

Certain zoonotic bacterial diseases, including avohilmo

3.54

1.84

1.2

1.4

—

Myocarditis

3.53

1.83

1.3

1.5

—

Adenomyosis (Endometriosis of uterus)

1.93

1.83

1.0

1.4

—

Pleural effusion

137

1.75

1.82

1.4

1.3

—

Amyloidosis

4.18

1.82

1.8

1.2

—

Malnutrition

4.18

1.82

1.2

1.6

—

Pedal cyclist injured in transport accident

152

1.71

1.82

1.2

1.4

—

Other respiratory diseases principally affecting the interstitium

175

1.66

1.82

1.8

1.3

—

Otitis externa

160

1.69

1.81

1.0

1.3

—

Persistent delusional disorders

2.27

1.80

1.1

1.4

—

Gout, unspecified

191

1.63

1.80

1.3

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

3.05

1.80

1.4

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

1.88

1.79

1.4

—

Benign neoplasm of urinary organs

2.76

1.79

1.0

1.5

—

Toxic effects of substances chiefly nonmedicinal as to source

2.17

1.77

1.5

—

Hallux valgus (acquired)

192

1.53

1.76

1.4

1.3

—

Urticaria

200

1.60

1.76

1.4

1.3

—

Erectile dysfunction

2.09

1.76

1.2

1.4

—

FESS (DNB20)

2.09

1.75

1.1

1.4

—

Presbycusis

175

1.64

1.74

1.2

1.3

—

Viral pneumonia (unknown virus, not influenza)

2.50

1.74

1.6

1.4

—

Postpartum hemorraghe, all women as controls

135

0.36

1.73

1.2

1.1

—

Other (seronegative) rheumatoid arthritis, wide

147

1.70

1.73

1.2

1.4

—

Other disorders of pigmentation

2.67

1.72

1.1

1.3

—

Mental and behavioural disorders due to sedatives or hypnotics

2.67

1.72

1.0

1.5

—

Injuries involving multiple body regions

2.92

1.72

1.9

1.2

—

Family history of certain disabilities and chronic diseases leading to disablement

2.92

1.72

1.0

1.2

—

297

1.45

1.72

1.3

1.4

—

Hepatocellular carcinoma

3.86

1.71

1.2

1.6

—

Prurigo nodularis

3.86

1.71

1.4

1.6

—

Chronic mastoiditis

3.86

1.71

1.0

1.2

—

Injury of muscle and tendon at ankle and foot level

3.86

1.71

1.2

1.5

—

Benign neoplasm: Skin of scalp and neck

3.86

1.71

1.0

1.2

—

Other congenital malformations of face and neck

3.86

1.71

1.2

—

Myeloproliferative diseases

2.14

1.71

1.7

1.4

—

ILD, hospital admissions

140

1.72

1.71

1.9

1.3

—

Other disorders of eyelid

398

1.40

1.71

1.3

—

Injuries to the elbow and forearm

566

1.32

1.71

1.2

1.3

—

DVT of lower extremities

163

1.66

1.70

1.4

1.3

—

Foreign body entering into or through eye or natural orifice

2.30

1.70

1.3

1.6

—

Other fall from one level to another

163

1.66

1.70

1.9

1.3

—

Allergic contact dermatitis

2.00

1.69

1.2

1.4

—

Rheumatoid arthritis, including avohilmo

332

1.45

1.68

1.2

1.3

—

Iridocyclitis

164

1.65

1.67

1.4

1.3

—

Hydrocephalus

2.19

1.67

2.9

1.4

—

Retinal haemorrhage

3.17

1.66

1.2

1.4

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

3.17

1.66

2.0

1.3

—

L01XE Protein kinase inhibitors

2.59

1.66

2.0

1.5

—

Tobacco use

2.59

1.66

1.3

1.6

—

Vulvovaginal ulceration/inflammation in other diseases

2.58

1.66

1.0

1.4

—

Thyrotoxicosis with diffuse goitre

1.86

1.65

1.4

1.3

—

Polyarthritis, unspecified

2.81

1.65

1.4

1.3

—

Viral infections of the central nervous system

2.44

1.64

1.0

1.5

—

Scoliosis

2.25

1.63

1.5

1.3

—

Hypocalcemia

3.58

1.61

3.4

1.2

—

IgA nephropathy (IgA glomerulonephritis)

3.58

1.61

1.6

1.1

—

Benign neoplasm: Duodenum

3.58

1.61

1.6

1.4

—

Aneurysms, operations, SAH

120

1.75

1.61

1.2

1.4

—

Female infertility, tubal origin

3.58

1.61

1.0

1.6

—

Endometriosis diagnosis and infertility diagnosis occurring together

2.38

1.61

1.1

1.3

—

Abnormal involuntary movements

1.84

1.61

1.2

1.4

—

Otalgia

2.15

1.60

1.1

1.4

—

Acute suppurative otitis media

140

1.66

1.60

1.4

—

Fracture of forearm

445

1.35

1.60

1.2

1.3

—

Diseases of external ear

303

1.45

1.59

1.1

1.3

—

Congenital malformations of the urinary system

2.50

1.59

1.8

1.5

—

Focal brain injury

2.50

1.59

1.3

—

Other joint disorders

381

1.30

1.59

1.2

1.3

—

Malignant neoplasm of pancreas, including Hilmo

2.00

1.59

1.2

1.4

—

Disorders of eyelid in diseases classified elsewhere

3.01

1.58

1.0

1.3

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

3.01

1.58

1.2

1.4

—

Traumatic subarachnoid haemorrhage

3.01

1.58

1.2

1.4

—

Benign neoplasm: Small intestine

2.70

1.58

1.4

1.5

—

Contusion of other and unspecified parts of foot

2.70

1.58

1.0

1.4

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

270

1.40

1.57

1.4

1.3

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

121

1.74

1.57

1.5

1.4

—

Acute bronchiolitis

3.01

1.56

1.8

1.1

—

Injuries to the shoulder and upper arm

107

652

1.27

1.56

1.1

1.3

—

Diseases of middle ear and mastoid

378

1.36

1.55

1.3

—

Foreign body on external eye

1.88

1.54

1.3

1.5

—

Foreign body in alimentary tract

2.43

1.53

1.5

1.3

—

Other and unspecified mood [affective] disorders

2.43

1.53

1.3

1.4

—

Other diseases of biliary tract

1.98

1.53

1.6

1.4

—

Other and unspecified diseases of blood and blood-forming organs

3.34

1.52

1.2

1.4

—

Other bullous disorders

3.34

1.52

1.6

1.2

—

Depression or dysthymia

279

1.35

1.52

1.3

1.4

—

Open wound of lower leg

115

1.74

1.52

1.5

1.4

—

Fenamates

1.72

1.51

1.2

1.5

—

Postpartum haemorrhage

104

0.40

1.51

1.2

1.1

—

Cluster headache, wide,, including avohilmo

2.60

1.51

1.3

1.5

—

Use of biperiden

2.60

1.51

1.3

1.4

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

242

1.43

1.51

1.2

—

Postpartum hemorraghe, parous women as controls

108

0.39

1.50

1.2

1.1

—

Contact with sharp glass

2.86

1.50

4.7

1.3

—

Autoimmune hepatitis, wide definition

2.86

1.50

1.3

—

Recurrent dislocation of patella

2.86

1.50

1.7

1.2

—

Haemangioma, any site

2.16

1.50

1.1

1.5

—

Early lumbar disc prolapse operation

2.16

1.50

1.5

1.3

—

Malignant neoplasm of breast, HER-positive

172

1.52

1.50

1.5

1.3

—

Malignant neoplasm of breast, ER-positive, including Hilmo

172

1.51

1.49

1.5

1.3

—

Recurrent or chronic depression

160

1.52

1.49

1.0

1.3

—

Certain conditions originating in the perinatal period

2.59

1.49

1.6

1.2

—

Malignant neoplasm of pancreas

2.07

1.49

1.3

1.4

—

Herpesviral [herpes simplex] infections, including avohilmo

162

1.61

1.48

1.4

1.3

—

Sub-endpoint used in defining T1D endpoints

238

1.49

1.48

1.2

1.4

—

Other inflammatory liver diseases

2.44

1.48

1.2

1.5

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

165

1.55

1.48

1.2

1.3

—

Interstitial lung disease endpoints

147

1.63

1.47

1.9

1.3

—

Other interstitial pulmonary diseases

147

1.63

1.47

1.9

1.3

—

Interstitial lung disease

147

1.63

1.47

1.9

1.3

—

Nonorganic sleeping disorders, excluding more controls

109

1.74

1.46

1.1

1.4

—

Alcohol withdrawal state with delirium

2.37

1.45

1.8

1.6

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

2.37

1.45

1.1

1.4

—

Secondary right heart disease

2.51

1.45

1.1

1.3

—

!Aliquae complicationes praecoces traumatis

2.51

1.45

1.3

1.4

—

Early complications of trauma

2.51

1.45

1.3

1.4

—

Cerebral cysts

2.50

1.45

1.4

—

Anterior Iridocyclitis

140

1.64

1.44

1.5

1.4

—

Carbimazole or st.post thyroidectomy, condition for graves disease

140

1.64

1.44

1.4

1.3

—

Endometriosis ASRM stages 3,4

140

1.64

1.44

1.1

1.2

—

Malignant neoplasm of colon

140

1.64

1.44

1.3

1.4

—

Haemangioma and lymphangioma, any site

2.12

1.44

1.1

1.5

—

Malignant neoplasm of other connective and soft tissue

3.14

1.44

1.0

1.4

—

Malignant neoplasm of brain

3.13

1.44

1.2

1.4

—

Cluster headache, wide

3.13

1.44

1.4

1.3

—

Ethmoidectomy

1.92

1.43

1.1

1.4

—

Other other unspecified disorders of the circulatory system

2.73

1.43

1.2

1.7

—

Benign neoplasm: Kidney

2.73

1.43

1.0

1.4

—

Other anxiety disorders

263

1.42

1.43

1.1

1.4

—

Pedal cyclist injured in noncollision transport accidents

1.97

1.43

1.2

1.5

—

Malignant neoplasm of endocrine gland

2.31

1.43

1.4

1.3

—

Hypermetropia

2.31

1.42

1.6

1.3

—

Dermatophytosis

1.79

1.42

1.1

1.4

—

Paracetamol or NSAID medication

1.87

1.41

1.1

1.6

—

Other diseases of stomach and duodenum

2.25

1.40

1.3

1.4

—

severe traumatic brain injury, does not include concussion

213

1.50

1.40

1.9

1.3

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

2.18

1.40

1.1

1.3

—

Superficial injury of shoulder and upper arm

1.85

1.40

1.3

1.4

—

Menorrhagia

144

1.47

1.37

1.3

—

Meniscus derangement

313

1.34

1.37

1.1

1.3

—

Bullous disorders

2.20

1.37

1.4

—

Benign neoplasm of brain and other parts of central nervous system

2.20

1.37

2.0

1.5

—

Other coagulation defects

2.20

1.37

1.0

1.4

—

Crohn disease (strict definition, all UC cases excluded)

2.61

1.36

1.2

1.4

—

Amenorrhoea

2.61

1.36

1.2

1.4

—

Syphilis, including avohilmo

2.95

1.36

1.2

1.4

—

Syphilis

2.95

1.36

1.2

1.4

—

Myositis

2.95

1.36

1.2

1.6

—

Sequelae of injuries of neck and trunk

2.95

1.36

1.4

1.3

—

therapeutic use

2.95

1.36

1.2

1.4

—

Acute alcohol intoxication ICD-9

2.95

1.36

1.0

1.4

—

Cystic kidney disease, including avohilmo

2.95

1.36

1.6

1.2

—

Colorectal adenocarcinoma

180

1.54

1.35

1.4

—

Other extrapyramidal and movement disorders in other diseases

207

1.50

1.34

1.2

1.3

—

Sudden idiopathic hearing loss

1.87

1.34

1.1

1.4

—

Spondyloarthritis

120

1.67

1.33

1.5

1.4

—

Viral infections of the central nervous system, including avohilmo

2.13

1.33

1.0

1.5

—

LSIL lesion of the cervix uteri

2.13

1.33

1.2

1.3

—

Viral warts

2.04

1.32

1.2

1.4

—

Other shoulder lesions

1.97

1.32

1.2

1.4

—

LSIL lesion of the cervix uteri, vagina or vulva

1.97

1.32

1.2

1.3

—

Other disorders of penis

1.97

1.32

1.3

1.4

—

Thyrotoxicosis, other and/or unspecified

152

1.58

1.31

1.4

1.3

—

Other specified and unspecified retinal disorders

2.51

1.30

1.2

1.5

—

Malignant neoplasm of mesothelium and soft tissue

2.51

1.30

1.0

1.4

—

Other congenital malformations of skin

2.51

1.30

1.2

1.6

—

Cramp and spasm

2.50

1.30

1.3

1.5

—

Other congenital malformations of skin, including avohilmo

2.10

1.30

1.2

1.4

—

Spondylopathies (FG)

1.84

1.29

1.8

1.3

—

Otitis media, unspecified

2.03

1.29

1.1

1.3

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

2.36

1.29

1.1

1.5

—

Hordeolum and other deep inflammation of eyelid

2.36

1.29

1.0

1.4

—

Dislocation, sprain and strain of joints and ligaments of knee

419

1.32

1.27

1.2

1.3

—

conjunctival haemorrhage

2.00

1.27

1.5

—

Other symptoms and signs involving general sensations and perceptions

2.29

1.27

1.3

—

Cardiomyopathies, Primary/intrinsic

1.79

1.27

1.5

1.3

—

Inflammatory diseases of prostate (prostatitis)

1.79

1.27

1.5

1.4

—

Alcohol-induced chronic pancreatitis

2.29

1.26

1.0

1.5

—

Calculus of kidney and ureter

260

1.42

1.26

1.3

—

Acute appendicitis, no complications

402

1.34

1.26

1.2

1.3

—

Suppurative and unspecified otitis media

215

1.44

1.25

1.3

1.4

—

Fitting and adjustment of other devices

268

0.62

1.25

1.3

—

Temporal arteritis

2.41

1.24

1.0

1.4

—

Giant cell arteritis with polymyalgia rheumatica

2.41

1.24

1.0

1.3

—

Crushed, pushed or stepped on by crowd or human stampede

2.22

1.24

1.1

1.4

—

Other and unspecified injuries of lower leg

2.00

1.23

1.1

1.4

—

Nail disorders

2.00

1.23

1.3

1.5

—

Soft tissue disorders related to use, overuse and pressure

220

1.46

1.22

1.2

1.4

—

Cardiomyopathy (excluding other)

1.77

1.22

1.5

1.3

—

Other menopausal disorders

107

0.52

1.22

1.2

1.4

—

Malignant neoplasm of endocrine gland, including Hilmo

2.04

1.22

1.4

1.3

—

Other noninfective disorders of lymphatic vessels and lymph nodes

2.64

1.21

1.2

1.5

—

Chronic nephritic syndrome

2.64

1.21

1.6

1.3

—

Sacroiliitis, not elsewhere classified

2.64

1.21

2.8

1.3

—

Triptan medication for migraine, min. 3 purchases

264

1.36

1.21

1.1

1.3

—

Cholesteatoma of middle ear

2.17

1.21

1.1

1.4

—

Other disorders of optic [2nd] nerve and visual pathways

2.17

1.21

1.6

1.5

—

Other follicular disorders

2.16

1.21

1.0

1.5

—

Polyneuropathies and other disorders of the peripheral nervous system

196

1.48

1.21

1.5

1.4

—

Inflammatory disease of uterus

1.80

1.21

1.2

—

Haemorrhage in early pregnancy

151

1.54

1.20

1.2

—

Adverse effects, not elsewhere classified

124

1.61

1.20

1.3

1.4

—

Preterm labour and delivery

140

1.57

1.19

1.0

1.2

—

Unspecified urinary incontinence

1.83

1.19

1.4

1.3

—

Other/unspecified disorders of vestibular function

2.31

1.18

1.0

1.4

—

Cluster headache, strict, including avohilmo

2.31

1.18

1.3

1.5

—

Papillary adenocarcinoma of thyroid gland

2.31

1.18

1.7

1.4

—

Keratitis

289

1.38

1.18

1.4

1.3

—

Intermittent heterotropia

2.31

1.18

1.5

1.4

—

Other and unspecified psoriasis

2.11

1.18

1.3

1.6

—

Malignant neoplasm of thyroid gland

2.11

1.18

1.5

1.3

—

Disorders of refraction and accommodation

180

1.49

1.18

1.2

1.3

—

Malignant neoplasm of colon, including Hilmo

172

1.51

1.18

1.3

1.4

—

Other peripheral vascular diseases

2.00

1.16

1.1

1.5

—

Pain and other conditions associated with female genital organs and menstrual cycle

1.65

1.16

1.1

1.3

—

Hepatocellular carcinoma, including Hilmo

2.51

1.15

1.2

1.5

—

Other secondary coxarthrosis

2.51

1.15

1.2

1.5

—

Meralgia paraesthetica

2.51

1.15

1.2

1.5

—

Car occupant injured in noncollision transport accident

2.50

1.15

2.2

1.2

—

Injuries to the ankle and foot

508

1.26

1.15

1.2

1.3

—

Other diseases of blood and blood-forming organs

2.05

1.15

2.3

1.4

—

Colon adenocarcinoma

110

1.64

1.15

1.3

—

Degenerative macular diseases

112

0.45

1.12

1.0

1.3

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

2.00

1.12

1.4

—

Thyroiditis

2.00

1.12

1.3

1.4

—

Malignant neoplasm of respiratory system and intrathoracic organs

158

1.47

1.12

1.2

1.3

—

Mycoses, including avohilmo

105

660

1.21

1.11

1.4

1.3

—

Early lumbar disc prolapse, operated

1.96

1.11

1.6

1.4

—

Radiculopathy

135

1.56

1.11

1.1

1.3

—

Lateral epicondylitis

1.78

1.10

1.1

1.4

—

Other epidermal thickening

2.26

1.10

1.0

1.5

—

Unspecified jaundice

2.26

1.10

1.0

1.3

—

Polypectomy (DHB20)

2.26

1.10

1.1

1.5

—

Autoimmune hyperthyroidism

2.26

1.10

2.0

1.3

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.67

1.09

1.4

—

Uterine polyps

137

0.60

1.09

1.3

1.4

—

Corneal scars and opacities

2.39

1.09

2.0

1.4

—

Congenital iodine-deficiency syndrome/hypothyroidism

2.39

1.09

1.4

1.3

—

Bacterial meningitis

2.39

1.09

1.6

1.5

—

Other acute skin changes due to ultraviolet radiation

2.39

1.09

1.2

1.4

—

Hypertensive Renal Disease

2.38

1.09

1.2

1.4

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

2.38

1.09

1.0

1.6

—

Allergic urticaria

1.95

1.08

2.5

1.4

—

Artificial joint operation, meniscal resection

109

578

1.21

1.08

1.3

—

Follow-up examination after treatment for conditions other than malignant neoplasms

194

1.37

1.08

1.3

—

Lesion of lateral popliteal nerve

2.19

1.08

1.3

1.6

—

Recurrent dislocation and subluxation of joint

2.19

1.08

1.1

1.3

—

413

1.29

1.08

1.2

1.3

—

Anomalies of dental arch relationship, including avohilmo

1.64

1.07

1.4

1.3

—

All dysplastic lesions of the cervix uteri

134

1.54

1.07

1.2

—

Diseases of the musculoskeletal system and connective tissue

197

1.32

1.07

1.3

1.4

—

Disorders of muscles

1.76

1.06

1.1

1.4

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.63

1.05

1.0

1.5

—

Dislocation, sprain and strain of joints and ligaments of elbow

2.12

1.05

1.3

1.4

—

Other and unspecified effects of external causes

186

1.45

1.05

1.2

1.3

—

Colon adenocarcinoma, helper endpoint

113

1.59

1.05

1.3

1.4

—

Pregnancy, childbirth and the puerperium

172

0.67

1.05

1.4

1.3

—

Malignant neoplasm of urinary organs

1.71

1.05

1.1

1.3

—

Delivery

192

0.69

1.04

1.2

1.3

—

Allergic conjunctivitis

447

0.73

1.04

1.3

—

Other and unspecified corneal deformities and disorders

2.28

1.03

2.2

1.3

—

Adenocarcinoma and ductal carcinoma of pancreas

2.28

1.03

1.0

1.4

—

Clear cell adenocarcinoma of kidney

2.28

1.03

1.2

1.4

—

Other specified/unspecified inflammatory spondylopathies

2.28

1.03

1.2

1.4

—

Open bite

2.28

1.03

1.6

1.4

—

Other abnormal uterine and vaginal bleeding

133

1.46

1.03

1.2

1.4

—

245

1.37

1.03

1.4

1.3

—

Other disorders of bladder

1.63

1.03

1.2

1.4

—

Acne vulgaris

2.06

1.02

1.3

1.2

—

Urolithiasis

289

1.35

1.02

1.3

—

Acute and subacute iridocyclitis

130

1.54

1.02

1.6

1.3

—

Endometriosis

146

1.39

1.02

1.1

1.3

—

Other disorders of bone

122

1.56

1.02

1.2

1.3

—

Pyogenic arthritis

1.92

1.02

1.4

1.3

—

Dysplasia of cervi uteri

1.54

1.01

1.2

1.3

—

Fall on and from stairs and steps

213

1.41

1.01

1.3

—

Other and unspecified rosacea

1.89

1.01

1.2

1.4

—

Cardiomyopathy, other and unspecified

1.88

1.00

1.4

—

Dermatophytosis, including avohilmo

563

0.77

1.00

1.1

1.3

—

Other infective otitis externa

2.00

1.00

1.1

1.6

—

Infectious mononucleosis

2.00

1.00

1.1

1.2

—

Infectious mononucleosis, including avohilmo

2.00

1.00

1.1

1.2

—

Disorder of lipoprotein metabolism, unspecified

1.62

0.99

1.3

—

Benign neoplasm: Skin of other and unspecified parts of face

1.71

0.98

1.2

1.4

—

Other diseases of upper respiratory tract

127

561

1.18

0.98

1.2

1.3

—

1.81

0.98

1.4

1.5

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

375

1.30

0.98

1.3

—

Benign neoplasm of other and unspecified female genital organs

2.18

0.98

1.8

1.6

—

Prepatellar bursitis

2.18

0.98

1.6

1.7

—

Failed induction of labour

2.18

0.98

1.2

1.1

—

Female infertility

1.50

0.97

1.0

1.3

—

Other and unspecified polyneuropathies, also in other diseases

173

1.45

0.97

1.4

—

Persons encountering health services in circumstances related to reproduction

264

1.29

0.97

1.2

1.4

—

Oral lichen planus, including avohilmo , including avohilmo

1.95

0.97

1.0

1.4

—

Excessive vomiting in pregnancy

1.95

0.97

1.0

1.3

—

Visual impairment including blindness (binocular or monocular)

1.85

0.96

1.3

1.4

—

Injury of unspecified body region

1.80

0.96

1.3

1.4

—

Ocular pain

1.80

0.96

1.2

1.4

—

Nummular dermatitis

1.85

0.96

1.1

1.5

—

Graves disease, strict definition

1.85

0.96

1.7

1.3

—

Somatoform disorder

100

1.60

0.96

1.5

1.4

—

Hypothyroidism, strict autoimmune

405

1.23

0.96

1.3

1.2

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

108

1.57

0.96

1.6

1.4

—

All dysplastic lesions of the cervix uteri, vagina or vulva

161

1.45

0.95

1.2

—

Injuries to the neck

157

1.47

0.95

1.5

1.4

—

Obstructed labour due to malposition and malpresentation of fetus

100

1.57

0.95

1.1

—

Other necrotizing vasculopathies

1.77

0.94

1.0

1.4

—

Pleural plaque with presence of asbestos

1.78

0.94

1.3

1.4

—

Presbyopia

1.89

0.94

1.0

1.5

—

Abscess of anal and rectal regions

1.89

0.94

1.9

1.5

—

Malignant neoplasm of urinary organs, including Hilmo

1.61

0.93

1.1

1.4

—

Hyperfunction of pituitary gland

2.23

0.93

1.7

1.5

—

Glaucoma, exfoliation

109

1.56

0.93

1.1

1.4

—

Persons encountering health services in other circumstances

370

0.72

0.92

1.2

1.3

—

Carcinoma in situ of breast, intraductal

1.73

0.92

2.0

1.3

—

Primary open-angle glaucoma

334

1.30

0.92

1.2

1.4

—

Carcinoma in situ, bladder

2.15

0.91

1.0

1.5

—

Chronic iridocyclitis

2.15

0.91

1.0

1.4

—

Varicella [chickenpox], including avohilmo

2.14

0.91

1.3

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

423

0.75

0.91

1.3

—

Atrophic disorders of skin

110

1.55

0.90

1.2

1.3

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

105

581

1.18

0.90

1.3

—

Other diseases of arteries and capillaries

1.75

0.90

1.1

1.5

—

Rash and other nonspecific skin eruption

1.75

0.90

1.5

1.3

—

Polyp of the female genital tract

139

0.65

0.89

1.3

—

Single spontaneous delivery

192

0.71

0.89

1.2

1.3

—

Malignant neoplasm of brain, including Hilmo

2.07

0.89

1.2

1.3

—

Trochanteric bursitis

111

1.53

0.87

1.1

1.4

—

Malignant neoplasm of thyroid gland, including Hilmo

1.86

0.87

1.5

1.3

—

Heterophoria

1.86

0.87

1.6

1.4

—

Carcinoma in situ of other and unspecified sites

2.00

0.87

1.0

1.5

—

Presence of other functional implants

379

1.23

0.87

1.4

1.2

—

Melanoma in situ

2.00

0.87

1.3

1.6

—

Other orthopaedic follow-up care

2.00

0.87

1.0

1.2

—

Hemiplegia

2.00

0.87

1.5

—

Other necrotizing vasculopathies (FG)

1.82

0.85

1.0

1.3

—

Fracture of neck

1.82

0.85

1.4

1.5

—

Vasomotor rhinitis (mode)

1.82

0.85

1.3

1.5

—

Parkinson's disease, strict definition

128

1.49

0.85

1.4

1.3

—

Nonsuppurative otitis media

125

1.46

0.85

1.2

1.3

—

Malignant neoplasm of rectum

1.67

0.85

1.4

—

Erosion of teeth , including avohilmo

170

1.41

0.85

1.1

1.3

—

Other strabismus

136

1.47

0.84

1.5

1.3

—

Giant cell arteritis

1.94

0.84

1.0

1.5

—

Sarcoidosis

1.59

0.84

1.6

1.4

—

Disorders of vitreous body

429

1.24

0.83

1.2

1.3

—

Pollen allergy

1.59

0.83

1.3

—

Other diseases of hard tissues of teeth

291

0.78

0.83

1.3

—

Complications predominantly related to the puerperium

139

0.58

0.83

1.0

1.2

—

Palmar fascial fibromatosis [Dupuytren]

140

0.57

0.82

1.1

1.4

—

Non-small cell lung cancer, adenocarcinoma

1.74

0.82

1.0

1.4

—

Benign neoplasm: Adrenal gland

1.74

0.82

1.0

1.5

—

Other contact dermatitis

1.74

0.82

1.1

1.5

—

Spontaneous rupture of synovium and tendon

1.69

0.82

1.4

—

Event of undetermined intent

1.88

0.81

3.5

1.5

—

Other disorders of patella

1.55

0.81

1.3

—

Childhood asthma (age<16)

1.87

0.81

1.5

1.0

—

Childhood asthma (age<16), excluding more controls

1.87

0.81

1.5

1.0

—

L02BX Other hormone antagonists and related agents

1.70

0.80

1.1

1.4

—

Other maternal disorders predominantly related to pregnancy

226

1.27

0.80

1.1

1.2

—

Wet age-related macular degeneration

199

1.36

0.79

1.3

—

malignant neoplasm of male genital organs

128

1.36

0.79

1.1

1.3

—

Myeloproliferative diseases (CML excluded)

1.73

0.79

1.8

1.4

—

Tuberculosis, IBD comorbidity

1.73

0.79

1.3

1.2

—

Malignant neoplasm of head and neck

1.73

0.79

1.2

1.5

—

Special screening examination for infectious and parasitic diseases

0.50

0.79

1.0

1.3

—

Dystonia

1.82

0.79

1.0

1.5

—

Foreign body or object entering through skin

1.82

0.79

1.0

1.5

—

Skin changes due to chronic exposure to nonionizing radiation

403

1.24

0.79

1.2

1.3

—

Malignant neoplasm of prostate

126

1.36

0.79

1.1

1.3

—

Bicipital tendinitis

0.00

0.78

0.0

1.7

—

Diseases of salivary glands

242

1.32

0.78

1.3

—

Mixed conductive and sensorineural hearing loss

1.53

0.78

1.4

—

Use of levodopa decarboxylase inhibitor

131

1.45

0.78

1.5

1.3

—

Dilated cardiomyopathy

1.56

0.78

1.4

—

Congenital malformations of the circulatory system

1.62

0.77

1.1

1.5

—

Parkinson's disease

140

1.43

0.76

1.4

—

Chronic rhinitis, nasopharyngitis and pharyngitis

243

1.32

0.76

1.4

—

Impotence

1.77

0.76

1.0

1.4

—

Additional codes for the location of defect, injury or illness

1.77

0.76

1.2

1.5

—

Other/unspecified reactive arthropathies

1.77

0.76

1.3

1.5

—

Astigmatism

1.76

0.76

1.5

1.4

—

Antenatal screening

0.55

0.76

1.0

1.1

—

Vestibular neuronitis

1.70

0.75

1.1

1.4

—

malignant neoplasm of male genital organs, including Hilmo

129

1.35

0.75

1.1

1.3

—

Nonorganic sleeping disorders

132

1.44

0.75

1.1

1.4

—

Degeneration of macula and posterior pole

401

1.21

0.75

1.3

—

Pedal cyclist injured in other and unspecified transport accidents

1.64

0.75

1.0

1.5

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1.60

0.74

1.6

1.3

—

Right bundle-branch block

2.09

0.74

1.4

1.3

—

Malignant neoplasm of eye, brain and central nervous system

2.09

0.74

1.2

1.4

—

Desensitization to allergens

2.09

0.74

1.2

1.5

—

Cerebral aneurysm, nonruptured

1.67

0.74

1.3

1.4

—

Superficial injury of forearm

1.67

0.74

1.1

1.3

—

Artrosis, including avohilmo

434

1.17

0.74

1.3

1.4

—

Malignant melanoma, including Hilmo

141

1.42

0.74

1.2

1.3

—

Other congenital malformations of the digestive system

2.07

0.74

1.2

1.3

—

Other general symptoms and signs

2.07

0.74

1.4

1.2

—

Other secondary gonarthrosis

1.84

0.73

1.4

—

Other and unspecified injuries of head

1.64

0.73

1.3

1.5

—

Disorders of vitreous body and globe

443

1.22

0.73

1.2

1.3

—

Varicella [chickenpox]

2.00

0.72

1.4

1.3

—

Pain in thoracic spine

100

1.50

0.72

1.1

1.4

—

Mental disorders, not otherwise specified

1.80

0.72

1.3

1.4

—

Open wound of ankle and foot

1.61

0.72

1.3

1.5

—

Benign neoplasm of other and unspecified endocrine glands

1.55

0.71

1.1

1.4

—

Leiomyoma of uterus

320

0.81

0.71

1.3

—

Assault by bodily force

1.75

0.71

1.9

1.4

—

Malignant neoplasm, without specification of site, including Hilmo

1.75

0.71

1.4

1.5

—

Other benign neoplasms of connective and other soft tissue

1.58

0.71

1.3

1.5

—

Sleep apnoea

102

556

1.16

0.70

1.2

1.3

—

Attention to artificial openings

1.93

0.70

3.0

1.4

—

Dementia in other diseases classified elsewhere

1.93

0.70

1.0

1.3

—

Alzheimer’s disease (Early onset)

1.71

0.70

1.4

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

1.71

0.70

1.1

1.3

—

Ptosis of eyelid

1.51

0.69

1.0

1.4

—

Dislocation, sprain and strain of joint and ligaments of hip

1.85

0.68

1.2

1.4

—

Other and unspecified abdominal hernia

1.85

0.68

1.2

1.4

—

Other vitreous opacities

1.85

0.68

1.2

1.4

—

Malignant neoplasm of ovary

1.85

0.68

1.8

1.4

—

Meningitis

1.85

0.68

1.6

—

Caries of dentine, including avohilmo

399

1.17

0.68

1.4

1.3

—

Malignant neoplasm of bronchus and lung

141

1.36

0.68

1.3

—

Other specified/unspecified hearing loss

1.56

0.68

1.1

1.4

—

Scabies, including avohilmo

1.56

0.68

1.0

1.4

—

Other noninflammatory disorders of vulva and perineum

1.53

0.68

1.0

1.3

—

Primary open-angle glaucoma, strict

283

1.27

0.68

1.2

1.4

—

Sleep disorders (combined)

100

600

0.87

0.67

1.2

1.4

—

Benign neoplasm: Rectum

153

1.37

0.66

1.3

—

Actinic keratosis

398

1.21

0.66

1.2

1.3

—

Open wound of wrist and hand

361

0.78

0.66

1.1

1.4

—

Abnormal blood-pressure reading, without diagnosis

1.79

0.66

1.4

1.3

—

Other and unspecified coagulation defects

1.79

0.66

1.0

1.5

—

Other obstructed labour

1.79

0.66

1.2

—

Female infertility, associated with anovulation

1.79

0.66

1.0

1.2

—

Other predominantly sexually transmitted diseases, not elsewhere classified

1.51

0.66

1.1

1.4

—

Other disorders of conjunctiva

111

1.44

0.65

1.4

—

Infections with a predominantly sexual mode of transmission

179

1.34

0.65

1.1

1.3

—

Other endocrine disorders

1.77

0.65

1.8

1.3

—

Parkinson's disease, including avohilmo

145

1.38

0.65

1.4

—

Tongue abnormality

1.59

0.65

1.1

1.4

—

Diseases of tongue

1.59

0.65

1.1

1.4

—

Diabetic maculopathy

105

1.44

0.64

1.3

1.6

—

Dermatographic urticaria

1.73

0.64

1.0

1.4

—

ILD, hospital admissions 1, main diag only

129

1.40

0.63

1.8

1.3

—

Deviated nasal septum

260

1.27

0.63

1.2

1.4

—

Temporomandibular joint disorders, including avohilmo

287

1.25

0.62

1.2

1.3

—

Alzheimer’s disease (Early onset), excluding more controls

1.68

0.62

1.4

1.3

—

Malignant neoplasm of bronchus and lung, including Hilmo

158

1.32

0.62

1.3

—

Vasomotor and allergic rhinitis

255

1.26

0.62

1.2

1.4

—

Hypertrophy of breast

104

0.58

0.61

1.0

1.3

—

Disorders of the thyroid gland

104

592

1.14

0.61

1.3

—

Disturbances of smell and taste

1.67

0.61

1.0

1.5

—

Other or ill-defined heart diseases

1.67

0.61

1.0

1.5

—

Other enthesopathies

217

1.29

0.61

1.2

1.3

—

Carcinoma in situ of cervix uteri

1.60

0.61

1.1

1.3

—

1.58

0.61

1.2

1.4

—

Other congenital malformations of the digestive system, including avohilmo

1.66

0.61

1.2

1.4

—

Localized swelling, mass and lump of skin and subcutaneous tissue

253

1.27

0.60

1.3

—

Non-small cell lung cancer, including Hilmo

130

1.37

0.60

1.1

1.3

—

Malignant neoplasm of prostate, including Hilmo

127

1.30

0.60

1.1

1.3

—

Nontoxic diffuse goitre

0.00

0.60

0.0

1.5

—

Other and unspecified injuries of shoulder and upper arm

0.00

0.60

0.0

1.5

—

Hyperkinetic disorders, excluding more controls

1.56

0.60

1.0

1.3

—

Other symptoms and signs involving the urinary system

1.50

0.59

1.5

1.4

—

Rosacea

1.50

0.59

1.2

1.4

—

Macular pucker

151

0.66

0.59

1.5

1.4

—

Endometriosis of rectovaginal septum and vagina

1.54

0.59

1.1

1.3

—

Optic neuritis

0.00

0.59

0.0

1.4

—

Disorders of optic nerve and visual pathways

1.54

0.59

1.6

1.4

—

Endometriosis of ovary

1.43

0.59

1.1

1.3

—

Malignant neoplasm of rectum, including Hilmo

1.44

0.58

1.6

1.4

—

Oxicams

139

0.73

0.58

1.5

1.6

—

Placenta praevia

0.00

0.58

0.0

1.4

—

Hypermobility syndrome

0.00

0.58

0.0

1.5

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

1.51

0.58

1.0

1.5

—

Unspecified lump in breast

112

0.62

0.58

1.4

1.3

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

130

1.37

0.58

1.0

1.3

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

1.48

0.57

1.1

1.5

—

Suggestive for eosinophilic asthma

1.48

0.57

1.3

1.5

—

Pleural plaque

1.48

0.57

1.3

1.4

—

Special screening examination for neoplasms

1.67

0.56

1.2

1.4

—

Social phobias

1.67

0.56

1.2

1.4

—

Diseases of pulp and periapical tissues, including avohilmo

117

538

1.12

0.56

1.3

—

Carcinoma in situ of skin of other and unspecified parts of face

0.57

0.56

1.6

1.3

—

Other inflammation of eyelid, including avohilmo

341

0.79

0.55

1.1

1.3

—

Lesion of plantar nerve

1.62

0.55

1.3

—

Perforation of tympanic membrane

1.54

0.55

1.1

1.4

—

Hypothyroidism, other/unspecified

569

1.13

0.55

1.3

—

Obesity, other/unspecified

230

1.26

0.55

1.3

1.2

—

Retinal breaks without detachment

123

0.65

0.54

1.1

1.4

—

Malignant neoplasm of bladder, including Hilmo

106

1.40

0.54

1.1

1.3

—

Transient global amnesia

1.48

0.53

1.0

1.4

—

Ectropion of eyelid

1.54

0.53

1.0

1.4

—

Achilles tendinitis

1.45

0.53

1.0

1.5

—

Burns and corrosions of external body surface, specified by site

1.45

0.53

1.6

1.5

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

108

1.39

0.53

1.1

1.3

—

Other keratitis

1.52

0.52

1.4

—

Ill-defined and unknown causes of mortality

0.62

0.52

1.0

1.4

—

Allergic rhinitis

185

1.28

0.51

1.2

1.4

—

Subjective visual disturbances

188

1.28

0.51

1.2

1.3

—

Benign lipomatous neoplasm

236

0.76

0.50

1.7

1.3

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

195

1.22

0.49

1.4

1.2

—

Malignant neoplasm of breast, including Hilmo

195

1.22

0.49

1.4

1.2

—

Tuberculosis, wide

1.49

0.49

1.3

1.4

—

Tuberculosis, wide, including avohilmo

1.49

0.49

1.3

1.4

—

Polyuria

198

1.26

0.49

1.2

1.4

—

Glaucoma-related operations

1.56

0.49

1.3

1.4

—

Pneumothorax

1.56

0.49

1.3

1.5

—

Pedestrian injured in transport accident

1.56

0.49

1.0

1.4

—

Acne

1.55

0.48

1.3

—

Medicines for HER+ breast cancer

286

1.20

0.48

1.4

1.3

—

Inguinal hernia

363

1.15

0.48

1.2

1.4

—

Ankylosing spondylitis, ICD10

1.52

0.48

1.1

1.5

—

Benign mammary dysplasia

111

0.63

0.48

1.0

1.3

—

Peritonsillar abscess

119

1.35

0.48

1.2

1.5

—

Malignant neoplasm of head and neck, including Hilmo

1.45

0.48

2.5

1.4

—

Fall on and from ladder

1.49

0.47

1.1

1.6

—

Persons with potential health hazards related to communicable diseases

231

0.77

0.47

1.1

1.4

—

Other disorders of cornea

1.47

0.47

1.7

1.4

—

Dentofacial anomalies [including malocclusion]

422

1.15

0.47

1.3

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

244

0.78

0.46

1.2

1.4

—

Ankylosing spondylitis

1.43

0.46

1.1

1.6

—

Burns and corrosions

1.43

0.45

1.5

1.4

—

Medical treatment for female infertility

102

1.36

0.45

1.0

1.1

—

Raynaud syndrome

1.40

0.45

1.1

1.4

—

Other superficial mycoses, including avohilmo

1.40

0.45

1.3

1.4

—

Squamous cell neoplasms and carcinomas of the skin

103

1.36

0.45

1.0

1.4

—

Infections with a predominantly sexual mode of transmission, including avohilmo

225

1.22

0.44

1.1

1.4

—

Postmenopausal bleeding

122

0.77

0.44

1.6

1.4

—

Malignant neoplasm of kidney, except renal pelvis

1.45

0.44

1.2

1.4

—

Other and unspecified visual disturbances

1.45

0.44

1.3

—

Bacterial, viral and other infectious agents, including avohilmo

1.37

0.44

2.0

1.5

—

Retained placenta and membranes, without haemorrhage

1.37

0.44

1.1

1.3

—

Polycystic ovarian syndrome, broad definition

1.37

0.44

1.0

1.2

—

Benign neoplasms

102

500

1.11

0.44

1.4

1.3

—

malignant neoplasm of female genital organs

110

1.33

0.43

1.6

1.4

—

Covid-19 suspected case

127

0.71

0.43

1.3

—

Dislocation, sprain and strain of joints and ligaments at neck level

1.41

0.43

1.5

1.4

—

Atypical facial pain

1.61

0.43

1.2

1.4

—

Childhood allergy (age < 16)

1.45

0.43

1.4

1.2

—

Other ill-defined and unspecified causes of mortality

0.66

0.42

1.0

1.4

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Norovirus Ag [Presence] in Stool

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS